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CHAPTER I
INTRODUCTION
Origin of The Thyroid Hormones
The thyroid gland, an endocrine gland lying across the trachea
lateroinferior to the thyroid cartilage, is the source and primary regulator of serum thyroxine (T4) concentrations (Taurog, 1978).

In addition

to thyroxine, its major hormone product, the thyroid gland also produces
small amounts of two other iodinated thyronine molecules:
ronine (T3) and reverse triiodothyronine (rT3)

triiodothy-

(Chopra!!~·,

1978).

The production of these hormones by the follicular cells of the thyroid
gland occurs in four steps:

1) elemental iodine is concentrated, 2)

tyrosine residues in the protein thyroglobulin are iodinated, 3) iodicoupl~d

nated tyrosines in thyroglobulin are

to form iodothyronine, and

4) the hormone product is released from thyroglobulin by enzymatic hydrolysis (Freiden and Lipner, 1972).

Every animal species found in nature

has specific cells or tissues capable of the first two steps, trapping
and storing elemental iodine in an organic form (Gorbman, 1978).

How-

ever, the ability to regulate the formation of iodinated thyronine residues from the oxidative coupling of two iodinated thyronine residues, and
the ability to regulate the subsequent enzymatic hydrolysis of the iodinated thyronine residues are biochemical phenomena found only in members
of the vertebrate animal kingdom (Gorbman, 1978).

Indeed, all adult mem-

bers of vertebrate species studied thus far have follicular thyroid cells
capable of producing the iodinated thyronines (Henderson and Gorbman,
1971).

l

2

In addition to the thyroid gland, other extrathyroidal tissues,
primarily the liver and kidney have been shown to contribute to the serum
concentrations of T3
1976).

(Braverman~~.,

1970) and reverse T3 (Chopra,

These peripheral tissues contain specific deiodinases which pro-

duce T3 and rT3 as a result of the monodeiodination of T4
1976a).

(Visser~~.,

It has been reported that as much as 80% of the circulating

serum T3 and as much as 97 % of the circulating reverse T3 may be derived
from the degradation of T4 in the peripheral tissues
1975a; Schimmel and Utiger, 1977).

(Chopra~~.,

The continued stepwise deiodination

of thyroxine in the peripheral tissues also results in the production of
diiodinated and monoiodinated thyronines (Chopra et at., 197Sa; Smallridge~~.,

1979; Pangaro !£~·' 1980).

The Thyroid Hormones

Thyroxine (T4)
Thyroxine was discovered by Edward Kendall on Christmas Day, 1914,
when the first purified crystals of thyroxine (T4) were obtained from an
alkaline hydrolysate of bovine thyroid glands (Kendall, 1929).

The pro-

duct he obtained was biologically active and gave a cherry red color when
reacted with nitrous acid (Kendall and Osterberger, 1919).

Kendall pro-

posed that the substance was an iodinated derivative of tryptophan and he
orignally named the compound thyroxindole.

Harrington and Barger identi-

fied the correct structure (Figure 1) in 1927, and changed the name of
the compound to thyroxine (Harrington and Barger, 1927).

Interestingly,

Kendall originally chose the name thyroxindole rather than the one that

3

Figure 1.

Molecular structure and numbering system for thyroxine (T4).

A. The molecular structure of thyroxine consists of an diiodosubstituted phenol ring attached to a diiodotyrosine by an ether linkage.
The oxygen bridge imposes an angle of 120° on the axis of symmetry between the 2 aromatic rings. Despite a steric hindrance by the bulky iodine atoms of the inner ring, molecular orbital calculations indicate
that the energy barrier to rotation of the outer ring about its axis of
symmetry is sufficient!~ low to allow rapid rotation at ~oom temperature
(Kollman!!~·, 1973). The chemical formula for T4 is:
C15H1104N l4·
Thyroxine has a molecular weight of 776.88 g/mol. Of its total weight,
1.8% is nitrogen and 65.4% is iodine. B. The adopted numbering system
for the aromatic rings is as shown. Primed numbers are used to number
the carbon atoms of the outer ring. The chemical name for thyroxine is:
1~beta-3,5-diiodo-4-(3' ,5'-diiodo-4'-hydroxyphenoxy)-phenyl-alpha-amino
proprionic acid. Thyroxine is classified in Chemical Abstracts as a derivative of the amino acid alanine: alanine,-3-[4-(4-hydroxy-3,5diiodophenoxy)-3,5-diiodophenyl].
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would emphasize the iodine component because he felt that it was the
structure of the organic nucleus and not the iodine content that gave the
hormone its physiologic activity (Kendal, 1929).

This original idea has

recently been proven to be true by demonstration of thyroid hormonal activity in halogen-free analogs of T4 (Jorgensen, 1978).
Trevorrow (1939) first proposed the presence of T4 in human serum
(Trevorrow, 1939).

He found that most of the iodine in plasma coprecipi-

tated with serum proteins and was extractable with organic solvents.

The

actual identification of plasma T4, however, was first accomplished nine
years later with the successful crystallization of T4 from human serum
(Taurog and Chaikoff, 1948).

More recently, studies using radioimmuno-

assay procedures have substantiated the existence of circulating T4, and
have indicated that it may account for up to 90 % of the total proteinbound plasma iodide

(Beckers~~.,

1972; Chopra, 1978).

serum concentrations of T4 are in the range of 4.5 to 11.5
(Chopra~~.,

Normal human
~g/100

mL

197Sa).

3,3' ,5-Triiodothyronine (T3)
Thyroid hormone and thyroxine (T4) became synonymous terms following the establishment of the structure of thyroxine in 1927, by Harrington and Barger.

For many years, thyroxine was considered the only

thyroid hormone, and clinicians began an effort to relate its serum concentrations to thyroid disease states.

Then, in 1954, Gross and Pitt-

Rivers reported the existence of a second iodinated thyronine 1n normal
human serum as well as in the thyroid gland itself (Gross and PittRivers, 1954).

This compound contained 3 iodine atoms and became known

6

as triiodothyronine (T3) (See Figure 2).
effective in treating myxedema.

This "new" hormone was

Studies in thyroidectomized rats showed

that T3 had a more rapid onset of action and was from 3 to 7 times more
potent than T4 in stimulating oxygen consumption and in preventing goiter
formation.

Therefore, these workers proposed that while T4 was the major

form in which thyroid hormone was secreted, triiodothyronine (T3) was the
more active form within the cells of the target tissues (Gross and PittRivers, 1954).

This theory is still valid and at the present time T3 is

considered to be the most physiologically active of the naturally occuring iodothyronines (Ingbar and Braverman, 1975; Latham et

~··

1976;

Chopra, 19i8; Jorgenson, 1978).
Triiodothyronine (T3), like T4 is produced by the thyroid gland,
however, the primary source of serum T3 is the enzymatic monodeiodination
of T4 to T3 in peripheral tissues (See Figure 3)
Chopra, 1978).

1970;

As a result of both thyroidal and peripheral production,

the human serum concentration of T3
ng/100 mL

(Braverman!!~··

(Chopra!!~·'

1975a).

~s

normally in the range of 92 to 190

The enzyme responsible for the conver-

sion of T4 to T3 removes a single iodine atom from the 5'-position in the
phenol ring of T4 and, therefore, is described as an iodothyronine 5'deiodinase.

The biologic significance of the conversion of T4 to T3 is

considered to be that of an activating pathway whereby T4 functions as a
prohormone.

3,3' ,5 1 -Triiodothyronine (rT3)
The enzymatic conversion of T4 to T3 in peripheral tissues leading
to increased plasma T3 concentrations is now well established.

In addi-

7

Figure 2.

Iodothyronines containing 3 iodine atoms per molecule.

The molecular configuration is shown for triiodothyronine (T3) and
reverse T3 (rT3). The outer ring of T3 has a single iodine substituant.
In comparison, the inner ring of rT3 has a single iodine substituant. By
convention, the lower number is llsed in the descriptive term, and a 3
instead of a 5 is used to indicate the position of iodine in the outer
ring of T3 and in the inner ring of rT3.

8

3,3',5- triiodothyronine (T 3)

3,3,5'- triiodothyronine (rT3)

9

Figure 3. Relative significance of thyroidal and extrathyroidal sources
of T3, T4 and reverse T3 (rT3).

An approximation of the amount of hormone excreted daily by the
thyroid gland, and the amount of hormone derived from the peripheral
deiodination of T4 each day is diagrammed based on data from previous
publications (Schimmel and Utiger, 1977; Chopra et al., 1978). Of the
approximate 90 ~g of T4 produced each day by the~hyroid gland, approximately 30 ~g (33 %) is converted to T3, a slightly greater amount, 43 ~
(48 %) is converted to rT3, and the remaining 17 ~g (19 %) is metabolized
by processes other than deiodination. (Figure based on diagram presented
by Schimmel and Utiger, 1977.)
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.......
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tion, the peripheral tissues also convert a nearly equal amount of T4 to
a second triiodothyronine commonly referred to as reverse T3 (Figure 3).
Reverse T3 (rT3) (Figure 2), is found in normal serum in a concentration
range of 27 to 62 ng/100 mL (Chopra~.!!.·, 1975a; Vagenakis ~ .!.!_.,
1975).

It is currently proposed that a specific monodeiodinase, "iodo-

thyronine 5-deiodinase" is responsible for the conversion at T4 to rT3
(Cavalieri~.!.!_.,

1977;

Kaplan and Utiger, 1978;

Chopra~.!.!_.,
Gavin~.!.!_.,

calorigenically inactive (Stasilli

~

1978; Sakurada
1980).

~

.!.!_., 1978;

In contrast to T3, rT3 is

.!.!_., 1959; Gavin et .!!_., 1977;

Chopra, 1978) and the conversion of T4 to rT3 is regarded as an inactivating pathway for T4 metabolism.

The iodothyronine 5-deiodinase is

responsible for the production of most, if not all, of the circulating
serum rT3 (Schimmel and Utiger, 1977;

Gavin~.!.!_.,

1977).

In addition to being calorigenically inactive, rT3 has also been
shown to have a negative effect on the calorigenic activity of both T4
and T3 (Pittman and Barker, 1959,

Pittman~.!!_.,

been used to treat hyperthyroidism (Benua

~.!!_.,

1960) and has actually
1959).

Reverse T3,

however, may not be antagonistic to T4 and T3 in all of its effects.

For

example, at pharmacologic doses, the effect of rT3 is as potent or more
potent than T3 in the inhibition of phosphodiesterase activity in rat
calvaria (Marcus et

~.,

mouse bone marrow cells

1975), and in stimulating erythropoiesis in
(Golde~.!!_.,

1976).

At normal concentrations,

however, rT3 appears to be more antagonistic than additive to the overall
thyroid effect (Chopra, 1978) and, therefore, is generally considered to
be a negative effector of thyroid hormone activity.

12

Other Thyroxine Metabolites
The thyroxine metabolites containing less than 3 iodine atoms per
molecule (See Figure 4) are considered to be of only minor physiological
importance.

These compounds have biological half-lives of less than one

hour, and normal human serum concentrations are in the range of from 0.8
to 17 ng/dL (Chopra~.!!.·, 1972; Burman!:!_.!!.·, 1977; Smallridge~.!!_.,
1979; Meinhold and 3churnbrand, 1978; Pangaro

~.!!.·'

1980).

These par-

tially iodinated thyronines are thought to be the result of continued exposure of T3 and rT3 along with their metabolites to the peripheral deiodinase enzymes.

For example, it has been shown that thyroidectomized

rats will metabolize radiolabelled T3 or rT3 in
.!!.·, 1956;

Flock~.!!,.,

1960).

v~vo

to 3,3'-T2 (Roche et

The in vitro conversion of T3 and rT3 to

3,3'-T2 in rat liver homogenates has also been demonstrated (Chopra,
1976).

These deiodinases are not to be confused with those normally

present in the thyroid and concerned with iodide conservation.

All of

the partially iodinated thyronines shown in Figure 4 have been detected
in normal human serum using radioimmunoassay procedures suggesting,
therefore, that thyroxine can be completely deiodinated in the peripheral
tissues.

The iodine released during peripheral deiodination is conserved

by the body (Surks and Oppenheimer, !969).

The Hormonal Status of Thyroxine
The physiological importance of T4 as an intrinsically active thyroid hormone has recently been questioned
Schwartz~.!!.·,

1971;

Oppenheimer~.!!.·,

(Braverman~.!!.·,

1972).

1970;

Increasing evidence

indicates that in the euthyroid state most, if not all, of the metabolic
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effect of the thyroid hormones can be attributed to T3.

During certain

disease states, when the serum ratio of T3 to T4 is decreased, the
contribution of T4 to the metabolic effect may increase, However, in the
normal healthy adult the contribution of T4 to the overall

~etabolic

effect of the thyroid hormones is estimated to be 15 % or less, and T4 is
thought to serve the body primarily as a reservoir of prohormone for T3
(Ingbar and Braverman, 1975; Chopra, 1978).
One way in which the relative contributions of T4 and T3 to the
biologic effect of the thyroid hormones has been estimated is on the
basis of daily turnover rates and the relative potency of T3 and T4.
Data now available indicate that the calorigenic activity of T3 is from 2
to 4 times greater than that of T4, and that from 1/3 to 1/2 of the T4
metabolized each day is converted to T3 in the peripheral tissues (Brown
~~·,

1974;

Braverman~

al., 1970).

Based on this data, Brown and

colleagues estimated that 65 % of the physiological effect of the thyroid
hormones produced each day is due to T3 while 35 % is due to T4 (Brown et
~.,

1974).

This estimate was later modified to reflect the fact that

rT3, which has less than 5 % of the calorigenic activity of T4 (Pittman
~~·,

1962; Stasilli

~ ~·,

peripheral metabolism of T4.

1959), is also a major product of the
Taking into account the metabolism of T4 to

rT3, the estimated contribution of T4 to the biologic effect of thyroid
hormones was reduced from 35% to about 14% (Chopra, 1978).

In addi-

tion, it was pointed out that the original estimate was based on a daily
turnover rate of 110

~g

T4/day.

If the more commonly observed value of

90 ug T4/day is used, the final estimate of the activity attributable
directly to intact T4 would decrease nearly to zero (Chopra, 1978).
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A second approach to determining the relative contribution of T4
and T3 to the metabolic effect of the thyroid hormones has been estimating the cross-reactivity of T4 with T3 at nuclear binding sites.

This

approach is based on the assumption that the binding of hormone to
nuclear binding proteins (NBP) is responsible for the initiation of hormonal action, and that the contribution of T4 and T3 to total hormonal
activity depends on the mass of T4 and T3 bound to the NBP sites (Oppenheimer and Surks, 1975; Mariash and Oppenheimer, 1980).

Perhaps the best

estimates of the binding capacities of nuclear sites have been generated
under in vivo conditions

(Latham!!~··

1976).

Binding studies by

Oppenheimer and colleagues utilized in vivo isotopic studies to determine
binding capacities pf T3 and T4 to rat hepatocytes
1974).

(Oppenheimer~~.,

Their results indicated that T4 binds to the same NBP sites as

T3, but with an association constant approximately 1/20 that of T3.

The

actual content of T3 and T4 bound specifically to the rat liver NBP was
calculated to be 20.3 x lo-13 and 2.83 x lo-13 mol/g liver tissue respectively

(Oppenheimer~~.,

1974).

This data predicts that the biologi-

cal effect of T3 exceeds the intrinsic contribution of T4 by a factor of
about 7, or that approximately 12 %of the total

met~bolic

activity of

the thyroid hormones is due to T4 (Oppenheimer and Surks, 1975).

Similar

results were predicted for the relative potency of the thyroid hormones
~n

man

(Oppenheimer~~.,

1974).

In another set of in vivo experiments propylthiouracil (PTU), a
potent inhibitor of the

iod~thyronine

5'-deiodinase, was given to hypo-

thyroid patients receiving supplemental thyroxine.

The administration of

PTU did not cause a significant change in serum T4 levels, however, it

•
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did result in decreased serum T3 levels and a modest increase in serum
thyroid-stimulating hormone (TSH) levels

(Geffner~~.,

1975).

Propyl-

thiouracil has also been shown to be associated with anti-T4 effects in
the rat (Oppenheimer~!!·' 1972).

Results from the studies with PTU

were interpreted to indicate that T3 may be the sole biologically active
thyroid hormone

(Oppenheimer~~.,

1972; Chopra, 1978).

Two theories have been proposed to explain why T3 has a greater
biological potency than T4.

The first theory suggests that the iodine in

the 5'-position of T4 creates steric hindrance to binding of T4 at receptor sites (Oppenheimer and Surks, 1975).

Binding to the functional

receptor would be more difficult for T4, therefore, than for TJ, which
has only one iodine atom in the phenolic ring.

The second theory is

based on the fact that at physiological pH, the 4'-hydroxyl group of T4
is dissociated while the 4'-hydroxyl group. of T3 is not (Latham
1976).

~!!·•

The presence of a single iodine in the phenol ring of T3 peturbs

the pKa (-log of the dissociation constant) of the 4'-hydroxyl group from
10.1 as in tyrosine to 8.40, and the second iodine in the phenol ring of
T4

~eturbs

1970).

the pKa of the 4'-hydroxyl group to approximately 6.46 (Smith,

It is suggested, therefore, that the presence of a 4'-hydroxyl

group at physiological pH gives T3 a greater binding affinity than T4 for
the functional receptor proteins of the target cell (Latham et
1976).

~·,

This theory has been supported by the demonstration that T3 binds

optimally to rat liver NBP at pH 7.6 and that T4 binds optimally to rat
liver NBP at pH 6.0

(Latham~

!!·• 1976;

Eberhardt~~.,

1979).

It

has also been shown that above pH 8.2, the binding affinity of T3 for rat
liver NBP decreases to a point equal to or less than the binding affinity

17
of T4 (Latham

!E._..!!..·, 1976).

Peripheral Metabolism of Thyroid Hormones
!odothyronines undergo transformations in the peripheral tissues by
three major routes:

conjugation, deiodination, and degradation.

Conju-

gation occurs in hepatic tissues and results in the formation of sulfate
ester and glucuronide conjugates which are excreted in the bile (Bhagavan, 1974; White

!E..!!..·•

1978).

There is normally a high tubular respor-

tion capacity for free T3 and T4, and very little if any thyroid hormone
is excreted in the urine (Adlkofer

!E..!!..·,

1980).

Deiodination occurs by

a specific set of enzymes which act in a stepwise manner to strip iodine
from either the inner or outer ring of the iodothyronines.

These enzymes

are located in the liver and kidney as well as many other peripheral
tissues (Chopra, 1977a).
ways:

Degradation occurs by several enzymatic path-

An hepatic aminotransferase is active in the deamination of both

iodotyrosines and iodothyronines and results in the formation of pyruvic
analogs of the thyroid hormones (White

!E..!!..·,

1978).

The formation of

acetic acid analogs occurs in the kidneys by a two-step process which
includes an initial deamination and a subsequent decarboxylation step
(Braverman et

~.,

1970).

The liver catalyzes an a-methylation of the

acetic acid analogs utilizing S-adenosylmethionine (SAM), and the liver
and kidney both catalyze the rupture of the diphenyl ether bridge, the
ortho hydroxylation of the phenol rings, and the degradation of the alanine side chain (White

!E..!!..·,

1978).

The three major routes are not

mutually exclusive and pyruvic acid and acetic analogues of T4, T3 and
rT3 are found in normal human serum

(Chopra~

..!!..·•

1978).
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Deiodination is the primary step in the catabolic pathway for
thyroxine.

It is estimated that of the total amount of T4 removed from

the plasma pool each day, 70 % to 80 % undergoes peripheral deiodination,
another 15 % to 20 % is conjugated and excreted in the bile, and the remaining 5 % to 10 % is deaminated or decarboxylated (Bhagavan, 1974;
Ingbar and Braverman, 1975;

White~~.,

1978).

The deiodination of T4 in the peripheral tissues is of uppermost
biological importance.

In addition to being the major catabolic route of

thyroxine metabolism, the bidirectional deiodination of T4 (See Figure 3)
is responsible for the production of approximately 80 % of the plasma T3
and 93 % or more of the plasma rT3 (Chopra, 1976; Schimmel and Utiger,
1977).

The continued stepwise deiodination of T4

~s

also responsible for

the presence of most if not all of the piasma mono- and diiodinated thy- ·
ronines

(Rudolph~~.,

Cahnmann, 1979).

1976;

Chopra~~.,

1978; Sorimachi and

A schematic diagram of the stepwise deiodination scheme

for thyroxine showing the possible steps and partially iodinated intermediates is shown in Figure 5.

The individual steps in the deiodination

sequence are presently thought to be catalyzed by enzymes which have a
high affinity and specificity for the iodothyronine substrates.
It is proposed that the enzymes active in the conversion of T4 to
T3 (5'-deiodinase) and of T4 to rT3 (5-deiodinase) are components of two
distinct enzyme systems.

Experiments have shown that the inner and outer

ring deiodinases have different pH optimum (Cavaleri

~~·,

and Utiger, 1978; Sorimachi and Robbins, 1979), and that the

1977; Kaplan
5'-

deiodinase and the 5-deiodinase have maximal activity in the particulate
and soluble fractions of cellular homogenates respectively (Cavalieri et
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Figure 5. Schematic diagram for the stepwise deiodination of thyroxine
in peripheral tissues.

The solid arrows indicate those steps catalyzed by an outer ring
monodeiodinase (5'-deiodinase). The outlined arrows indicate those steps
catalyzed by an inner ring monodeiodinase (5-deiodinase).
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~·~

1977; Chopra, 1977a).

Perhaps the most convincing evidence of two

distinct enzyme systems is a reciprocal relationship that exists between
T3 and rT3 concentrations in normal cord umbilical serum and in serum
from patients suffering from a variety of nonthyroidal illnesses (Table
1).

These conditions are characterized by normal or near normal levels

of serum T4, decreased levels of serum T3 and a corresponding increase in
serum rT3.

Were there only a single enzyme catalyzing the conversion of

T4 to T3 and T4 to rT3, one would expect the serum levels of T3 and rT3
to increase or decrease in parallel.
The bidirectional conversion of T4 to T3 and rT3 offers a mechanism
whereby T4 can act as a prohormone and be activated by conversion to T3
or be

deactivat~d

by conversion to rT3.

Therefore, an analogy to vitamin

D3 metabolism has been proposed for the metabolism of T4.

For example,

tn the metabolism scheme for vitamin D, 25-hydroxy-cholcalciferol is converted by a double enzyme system in the kidney to either the biologically
active 1,25-dihydroxy form or to the inactive 24,25-dihydroxy form of
'litamin D

(DeLuca~~·,

1973).

When 1,25-(0H) 2 -D3 production is

decreased, there is a corresponding increase in the production of 24,25(0H)2-o3 and vice versa (Tanaka and DeLuca, 1974).

The peripheral deio-

dination of T4 to T3 and rT3 1s quite similar in that it is also thought
to be controlled by a double enzyme system consisting of the S-and 5'deiodi~ase

enzymes, and as indicated in Table 1, a decrease in the levels

of T3 are associated with a corresponding increase 1n serum rT3 levels in
a variety of "sick euthyroid" conditions.
The mechanism by which the body controls the bidirectional deiodinase system to result in decreased serum T3 levels is presently unknown.
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Table 1
Reciprical Relationship of Serum T3 and rT3 Concentrations
During Non-Thyroidal Illness and in the Newborn

Study

TOTAL*

Group

T4

Newborn
Cord
serum

t

Hepatic
Cirrhosis

t

Chronic
Renal
Failure
Acute
Febile
Illness
Protein
Calorie
Malnutrition

t
t
t

T3

'

·t"'

l

'

FREE*
rT3

T4

t

t

t

t
t
It

T3

rT3

t

'J

t
t

t

t

t

t

t

*Increased and decreased values for total and free (dialyzable) hormone
levels are based on serum concentrations for each study group as reported
by Chopra and colleagues (Chopra et al., 1975a). The size of the arrows
are roughly proportional to relative-rncreases or decreases in serum hormone concentration.
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It has been proposed that a decrease in the concentration of the active
5'-deiodinase, or reductions in intracellular cofactor (reduced glutathione, NADPH) concentrations during starvation, stress and febrile illness might be responsible for the reduced iodothyronine 5'-deiodinase
activity (Balsam and Ingbar, 1979;

Harris~~.,

1979).

In addition, it

has been suggested that glucocorticoids, which have an inhibitory effect
on the conversion of T4 to T3, may also be involved with the reduction in
5'-deiodinase activity

(Chopra~~.,

1975a; Westgren

~~.,

1977).

Increases in serum rT3, on the other hand, result from decreased degradation rates as well as increased production, and inhibition of the 5'deiodinase that metabolizes rT3 to 3,3'-T2 is thought to be a major contributor to increased serum rT3 levels (Kaplan and Utiger, 1978; Lumholtz
~~.,

1979).

Within the past 10 years, the importance of iodothyronine 5'deiodinase in regulating serum levels of T3 and, therefore, in potentiating the biologic effect of thyroxine has been recognized.

As a result

of increased interest in the extrathyroida1 metabolism of thyroxine, a
major effort is currently being made by numerous groups to elucidate the
biochemical properties of the 5 '-deil,dinase and to determine what factors
affect the catalytic rate of T4 to T3 conversion.

Iodothyronine 5'-Deiodinase
The possibility that T3 might be derived from the conversion of T4
to T3 in the peripheral tissues in addition to direct thyroidal secretion
was first proposed by Pitt-Rivers and colleagues in 1955 (Pitt-Rivers et
~.,

1955), and the first evidence of the in vitro, extrathyroida1 con-
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version of T4 to T3 was reported by Albright and Larsen (1959).

Interest

in the deiodinase system was slow to develop, however, because it had not
been conclusively demonstrated in vivo that T4 was converted to T3 in
peripheral tissues (Lassiter and Stanbury, 1958).

Therefore, the ques-

tion lay dormant until 1970, when Braverman, Ingbar and Sterling demonstrated the conversion of T4 to T3 in athyroidic patients maintained on
highly purified T4

(Braverman~~.,

1970).

At first the peripheral

conversion was proposed to be a nonenzymatic random deiodination (Surks
and Oppenheimer, 1971).

This proposal was widely accepted because T4 was

deiodinated to T3 and rT3 in approximately equal amounts, and because in
vitro assays in crude homogenate systems failed to show substrate saturation (H~fner and Kh~pfle, 1976).

In 1975, Vagenakis and colleagues de-

monstrated that rT3 increased corresponding to a decrease in T3 in serum
from fasting patients (Vagenakis
again to an enzymatic mechanism.

~~.,

1975), and interest turned once

Fisher and Sack proposed that the re-

action was catalyzed by tyrosine hydroxylase (Fisher and Sack, 1975).
This proposal was subsequently discounted on the basis that alphamethyl-para-tyrosine, a specific inhibitor of tyrosine hydroxylase, did
not affect the in vitro deiodination of T4 (H~fner, ~~., 1977).
Finally, in 1977, Chopra demonstrated in vitro substrate saturation by
T4, and demonstrated that the deiodinase activity was enzymatic in nature
(Chopra, 1977a).

Since 1977, the 5'-deiodinase has been studied in a

variety of animal systems both in vivo and in vitro.
Iodothyronine 5'-deiodinase activity has been observed in all vertebrate species studied.

In mammalian species, the enzyme is present in

the highest concentrations in the kidney, liver, and pituitary tissues
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(Chopra, 1977a; Cheron !!!l·' 1980).

Muscle, heart, spleen, brain, in-

testine, and thyroid tissues contain smaller amounts of activity (Chopra,
1977a;

Ishii~~.,

1981).

Polymorphonuclear leukocytes (Woeber and

Maddux, 1978), lymphocytes (Kvethy, 1978), and fibroblasts (Refetoff et
~.,

1972) also have been shown to have 5'-deiodinase activity.
Within the cell, 5'-deiodinase activity appears to be distributed

throughout the cellular membranes with the microsomal and plasma membrane
fractions being particularly rich in enzyme activity.

After conventional

subcellular fractionation (de Duve !! !l·, 1955), the largest single
fraction of T4 to T3 converting activity is the crude microsomal fraction
(Visser!! !l·, 1976b; Takaishi _!! !l·, 1979).

This fraction, however,

contains no more that 50 % of the total cellular activity, and results
from more elaborate fractionation studies have shown that of the activity
in the crude microsomal and nuclear fractions, a major portion of the 5'deiodinase co-purifies with enzyme markers associated with the plasma
membrane fraction (Maciel !! !l·, 1979).
Iodothyronine 5'-deiodinase activity has been studied in vitro 1n
numerous laboratories using crude membrane preparations or whole cell
homogenates of various tissues.

There has been no report of a successful

solubilization of an active form of the enzyme, and all studies have been
performed on

particulat~

preparations of the 5'-deiodinase.

The most

purified particulate preparations thus far achieved have been microsomal
membrane preparations which have allowed increases in specific activity
of from 2-to 6-fold in comparison to the crude homogenate preparations
(Visser_!! !l·, 1976b; Hoffken _!! .!!_., 1978; auf dem Brinke!! !l·,
1979).
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Iodothyronine 5'-deiodinase activity has been shown to be sensitive
to both temperature and pH.
be 37 °C (Chopra, 1977a).

The temperature optimum has been reported to
Preincubation of enzyme preparations for 60

minutes at 24 °C, 37 °C, and 56 °C resulted in the loss of 15 %, 43 %,
and 98 %, respectively of the recoverable activity (Chiraseveenprapund et
~.,

1978).

Optimum pH values at 37 °C have been reported in the range

of 6.0 to 7.35 (Hgffken !!~·' 1977; H~fner !!~·' 1977; Chopra,
1977a).
Iodothyronine 5'-deiodinase activity has been reported to be linear
with time (37 °C) during the initial 45 to 60 minutes of incubation
(Chiraseveenuprapund

!!~·'

1978;

Sorima~hi

and Robbins, 1979).

Linear-

Lty with protein concentration, however, has not been observed for the
crude enzyme preparations (Leonard and Rosenberg, 1977; Sorimachi and
Robbins, 1979).
The current literature has been inconsistent

concern~ng

the effects

of various ions on the activity of the 5'-deiodinase, however, it has
been generally agreed that there are no requirements for metal cofactors
(Kaplan and Utiger, 1978) and that the ions:
K+ do not have a major inhibitory or stimulatory effect (Visser!!~·'
1976b; Chopra, 1976; Sorimachi and Robbins, 1979).
including:

Heavy metal ions

zinc, mercury, lead, and silver, on the other hand, have been

shown to be potent dose-dependent inhibitors of the 5'-deiodinase (Chopra, 1977b).
It has recenlty been observed that several sulfhydryl agents including dithiothreitol (DTT), mercaptoethanol, cysteine, and reduced glutathione are potent stimulators of iodothyronine 5'-deiodinase activity

27

(Chopra, 1977b;

Harris~~.,

1979).

On the other hand, oxidized gluta-

thione has befon shown to inhibit monodeiodination

(Chopra~~.,

1978).

In addition, the sulfhydryl oxidizing agent, diamide, and the sulfhydrylbinding agent N-ethylmaleimide have also been shown to be potent inhibitors of the 5'-deiodinase

(Chopra~~.,

1978).

Based on these data and

the demonstration of thiol dependent activity in microsomal preparations,
it has been proposed that the presence of thiol-containing compounds is
essential for 5'-deiodinase activity

(Chopra~~·,

Robbins, 1979; Leonard and Rosenberg, 1980b).

1978; Sorimachi and

The naturally occuring,

endogenous cofactor has been proposed to be reduced glutathione (Visser
~~.,

1976b;

Chopra~~.,

1978;

Harris~~.,

1979).

NADPH has been

proposed to have an activating e;fect in vivo as a reductant for regener-

atin~ reduced glutathione (Balsam and Ingbar, ·1978; Chopra~~·, 1978).
No other chemical activators or dialyzable cofactors of the 5'-deiodinase
have been reported.
The stimulation of T4 to T3 conversion by the presence of thiol
group-containing compounds has been proposed to result in part from their
efficiency in maintaining the 5'-deiodinase in its active conformation
(Chopra~~·,

1978).

It is suggested, therefore, that the enzyme may

exist in an inactive conformation characterized by disulfide linkages
between cysteine residues, and that in the active conformation these
disulfide bonds are reduced.

In addition, it has been proposed that the

thiol group-containing compounds may act as cofactors and participate
directly in the reductive deiodination of T4

(Chopra~~.,

1978; Vis-

ser, 1979).
In addition to sulfhydryl-binding and sulfhydryl-oxidizing agents,
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the 5'-deiodinase is inhibited in a dose-dependent manner by various T4
metabolites including:

rT3, 3' ,5'-T2, and 3,3'-T2 as well as by propyl-

thiouracil, sodium salicylate, and some iodinated x-ray contrast agents
(Visser~.!.!_.,

1978;

Chopra~.!.!_.,

1978;

Chopra~.!.!_.,

1980).

Pro-

pranolol, a beta-adrenergic blocking agent, has also been reported to
have an inhibitory effect on the in vitro conversion of T4 to T3 (Lumholtz

~

.!.!_., 1979; van Noordan

~

.!.!_., 1979).

Reverse T3, the most

potent inhibitor of the various agents studied so far, has been reported
to be both a competitive inhibitor with K1 's of 0.045 ~mol/L (Chopra,
1977a) and 0.0045

~mol/L

(Kaplan and Utiger, 1978), and to be a non-

competitive inhibitor (K 1

a

0.02 ~mol/L (H~fner, 1977).

Propylthiouracil

has been reported to be an uncompetitive inhibitor with respect to T4
concentration, a competitive inhibitor with respect to dithiothreitol
concentration (Visser
and Utiger, 1978).

~

.!.!_., 1978), and an allosteric effector (Kaplan

Sodium salicylate and the iodinated x-ray contrast

agents have been reported to be competitive inhibitors
1978;

Chopra~.!.!.·,

1980).

(Chopra~.!.!.·,

The conversion of T4 to T3 is reported not

to be affected by dexamethasone (Kaplan and Utiger, 1978); by T3 (H~fner
~~.,

1977); by 3,5-T2, iodotyrosines; nor by methylated, brominated,

or chlorinated analogs of rT3

(Chopra~~··

t978).

Iodothyronine 5 '-deiodinases catalyze the .:;onversion of rT3 to
3,3'-T2 as well as the conversion of T4 to T3 (See Figure 5).

The simi-

larities in these 2 steps has led to an ongoing debate over whether the
same enzyme catalyzes both reactions.

Several findings suggest that both

steps are carried out by the same enzyme.

First, the tissue distribution

and subcellular location of both 5'-deiodinases is similar

(Chopra~
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~.,

1978).

Secondly, both activities require the presence of

thiol-

group-containing compounds for activity and both are inhibited by propylthiouracil in an uncompetitive manner

(Chopra~~.,

1978).

Thirdly,

rT3 is an inhibitor of T4 to T3 conversion and T4 is an inhibitor of the
rT3 to 3,3'-T2 deiodinase

(Visser~~.,

1979b).

In addition, both

activities have been shown to decrease during· fasting and hypothyroidism,
and to increase in response to hyperthyroidism (Kaplan and Utiger, 1978).
There are, however, several findings that do not support a one enzyme
theory.

For example, the Km of rT3 for the 5'-deiodinase (65 nmol/L rT3)
~mol/L

is approximately 40-fold lower than the Km of T4 (3.0

T4), and the

optimum pH for the T4 to T3 and rT3 to 3,3'-T2 activities are 6.5 and
8.0, respectively

(Visser~~.,

1979b).

Moreover, while the character-

istically low serum T3 and T4 to 13 converting activity in tissues of the
fetus increase to normal adult levels within a few hours of birth, the
characteristically high serum rT3 levels in the fetus do not decrease to
adult levels until the second week of postnatal life
1979).

(Maciel~~.,

If the outer ring deiodinases for T4 and rT3 were identical, one

would expect the changes to be more nearly synchronized.

Thus, while the

two activities are similar in some respects, the question of similarity
versus identity awaits purification of the 5'-deiodinase.
Kinetic studies utilizing crude membrane preparations have been
performed by several groups to determine the Michaelis-Menten constant
(Km)

and the velocity for the conversion of T4 to T3.

The apparent Km

for the 5'-deiodinase of these crude preparations has been reported to be
in a range of from 0.8 to 7.7 ~mol/L T4 (H~fner ~~., 1977; Chopra,
1977a; Kaplan and Utiger, 1978; auf dem Brinke

!!~·,

1979), and the

30
velocities of the most purified membrane preparations have been reported
typically to be in a range of from 0.5 to 1.2 pmol T3 min-lmg-1 (Takaishi
et al., 1979; Leonard and Rosenberg,
--

l980b).

Iodothyronine 5'-deiodinase is thought to catalyze the reductive
deiodination of T4

(Visser~~.,

l976b).

It is proposed that a

T4 + 2 R-SH - - + T3 + HI + R-SS -R
thio1-group-containing compound (R-SH) acts as a second substrate and
that the products of the reaction are T3, HI and the oxidized thiol.

It

is also proposed that the conversion of rT3 to 3,3'-T2 occurs by the same
mechanism (Visser et

~·,

l979b).

When the kinetics of the outer ring deiodination of rT3 to 3,3'-T2
were examined using different concentratio!J,S of DTT over a range of rT3
concentrations, the concentration of DTT added to the enzyme assay mixture was found to affect both the Km and maximum velocity such that a
family of parallel lines was generated when a double reciprical plot of
velocity

vers,~s

rT3 concentration was plotted at differing concentrations

of dithiothreitol (Visser, 1979).

This type of kinetic data is charac-

teristic of a two-step or ping-pong mechanism in which the enzyme oscillates between two stable forms (Cleland, 1963).

Visser and colleagues

suggested that the conversion of rT3 to 3,3'-T2 might occur by a pingpong mechanism where (E-SH) represents the active form oi the

\L3'-T2,

rT3

E-SH

2 R-SH

\/SS~R
E-S I

[rT3•ESH]

E-SH + HI

31
enzyme and (E-5I) represents a stable intermediate sulphenyl iodide (RSI) form of the enzyme

(Visser~~.,

1979b).

According to this type of

mechanism, the deiodination reaction occurs in two steps.

The first step

was proposed to involve a concerted mechanism whereby a primary attack of
the rT3 substrate by an enzyme sulfhydryl group resulted in a

enzyme-

hormone complex (rT3•E-SH) which subsequently broke apart releasing free
3,3'-T2 from the iodinated enzyme (E-SI)

(Visser~~.,

1979b).

In the

second step, the oxidation of two thiol equivalents reduced the enzyme
back to its original active form and allowed the release of free hydrogen
iodide (HI).
The proposed ping-pong mechanism has been supported by the demonstration that propylthiouracil (PTU) inhibits the 5'-deiodinase uncompetitively with respect to rT3 and competitively with respect to dithiothreitol (Visser, 1979).

It has been demonstrated that the reaction of

iodine with protein yields sulphenyl iodides which are highly reactive
towards thiouracil derivatives (Cunningham, 1964).

Competition between

PTU and dithiothreitol for the sulphenyl could, therefore, explain the
competitive inhibition with respect to dithiothreitol.

By binding to the

sulphenyl, PTU would effectively lower the concentration of active enzyme
available for the deiodination of rT3, and

t~is

could explain the appa-

rent uncompetitive inhibition with respect to rT3.

These results are

consistent with the formation of a sulphenyl iodide enzyme intermediate.
The T4 5'-deiodinase is also inhibited in a competitive manner by
PTU with respect to T4 (Chopra, 1977a).

Therefore, it has been proposed

that the deiodination of T4 to T3 also occurs by a ping-pong mechanism
(Visser~~··

1979b).

Other reports, however, have suggested that the
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Km of the T4 5'-deiodinase is not affected by the concentration of dithiothreitol (Chopra, 1977b).

If this is true, it would indicate that the

conversion of T4 to T3 does not occur by the ping-pong mechanism.
Due to the particulate nature of the iodothyronine 5'-deiodinase,
purification of the enzyme requires membrane extraction.

Preliminary

studies have shown that solubilization of the 5'-deiodinase from rat
liver microsomal preparations requires detergent concentrations sufficient to result in extensive membrane dissassembly (Takaishi et al.,

--'

1979).

Therefore, instead of being adsorbed to the membrane surface (ex-

trinsic protein) or being included within luminal cavities of microsomal
vesicles (matrix protein), the iodothyronine 5'-deiodinase was found to
be an integral component (instrinsic protein) of rat liver microsomal
membranes.
Previous attempts to solubilize the 5'-deiodinase from rat liver
and kidney membranes (Takaishi

!!~·'

1979; Leonard and Rosenberg,

1980a, 1980b) and from beef liver membranes (Tseng and Ltham, 1981) demonstrated that deoxycholate was effective in solubilizing approximately
60 % of the deiodinase from cellular membranes, however, the enzyme was
inactive in the presence of even small amounts of the detergent (Leonard
and Rosenberg, 1980) and removal of deoxycholate by QAE-Sephadex chromatography, dialysis or adsorption techniques was required to demonstrate
activity in solubilized fractions.

After detergent removal, the 5'-

deiodinase could be stored for 3 days at 4 °C, or for 1 month 3t -70
with little or no loss in activity (Leonard and Rosenberg, 1980b).

oc

The

extracted enzyme was poorly soluble in aqueous buffers, however, and the
removal of detergent resulted in the formation of macromolecular aggre-
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gates of the enzyme.

These aggregates were excluded from Sepharose 6B-CL

when gel filtration was performed in the absence of detergent, and they
were shown, by isopycnic banding to have a membrane-like density of approximately 1.17 g/mL (Leonard and Rosenberg, 1980a).
The membrane-like density is suggestive of the presence of phospholipid and, in fact, the presence of phospholipid has been demonstrated to
be essential for catalytic activity.

Phospholipase A2 treatment of the

solubilized enzyme resulted in a concentration and time dependent loss of
T4 to T3 converting activity, and the addition of soybean phospholipid
prevented the lipase inactivation in a competitive manner (Leonard and
Rosenberg, !980a).
Gel filtration of the solubilized iodothyronine 5'-deiodinase in
the presence of deoxycholate allowed elution of T4 to T3 converting activity after the void volume.

The molecular weight of the deoxycholate

solubilized 5'-deiodinase from rat kidney membranes was estimated by
Sepharose 6B-CL chromatography in the presence of Na deoxycholate to be
approximately 85,000 (Leonard and Rosenberg, 1980a).

A 5'-deiodinase

enzyme complex solubilized from beef liver membranes has been reported to
have 2 included components when chromatography was performed on agarose
0.5 M ln the presence of Na deoxycholate.

The apparent molecular weights

of the 2 components were estimated to be 95,000 and 200,000 (Tseng and
Latham, 1981).
Attempts to purify the solubilized iodothyronine 5'-deiodinase in
the presence of deoxycholate have resulted in extremely low yields of active enzyme.

Gel filtration chromatography, for example, resulted 1n

yields of less than 10% (Leonard and Rosenberg, 1980b).

The poor re-
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covery of activity was found to be due in part to delipidation during gel
filtration as evidenced by a 5-fold increase in percent yield following
the addition of membrane lipid extracts (Leonard and Rosenberg, 1980b).
In addition to attempts to purify the 5'-deiodinase by gel filtration
chromatography, the mention of a preliminary attempt to purify the 5'deiodinase by adsorption chromatography on QAE-Sephadex and by fractionation with ammonium sulfate has been reported in abstract form (Tseng and
Latham, 1981).

To date, no other purification attempts have been pub-

lished and no successful purification of the 5'-deiodinase has been
reported.

The Present Study
A large body of evidence in the literature supports the existence
of a specific membrane-bound iodothyronine 5'-deiodinase that catalyzes
the conversion of T4 to T3.

There is also substantial evidence to sug-

gest that T3 is several times more biologically active than T4.

There-

fore, the 5'-deiodinase has recently been the subject of intense investigation due to its potential role in the pathogenesis and treatment of
thyroid disease.

The present study was undertaken in the interest of

illuminating the physical and enzymatic characteristics of the iodothyronine 5'-deiodinase.
At the present time, very little information is available regarding
the physical properties of the 5'-deiodinase, and there is considerable
disagreement among the various investigations of the enzyme's catalytic
activity.

This is due, in part, to the fact that the enzyme has only

been studied in crude preparations of whole cell homogenates and micro-
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somal membranes.
iodoth~ronine

I now report a technique for the membrane extraction of

5'-deiodinase, and the development of a multistep purifica-

tion procedure.

The purification procedure was used to prepare purified

thyroxine 5'-deiodinase from rat liver membranes for use in the investigation of physical properties and kinetic characteristics.
Physical characterization studies included the estimation of apparent molecular weight and the determination of isoelectric point for the
rat liver iodothyronine 5'-deiodinase.
Catalytic characterization studies involved the determination of
optimum conditions for enzymatic activity, the determination of Km and
VMax' and a study of inhibition by several known inhibitors including reverse T3, propylthiouracil, iodipamide, sodium salicylate, and proprano· lol.

A

p~ng-pong

rT3 to 3,3'-T2

mechanism has been proposed for the 5'-deiodination of

(Visser!!~.,

1979b).

In the present study, kinetic as-

says utilizing the purified rat liver 5'-deiodinase were performed for
the conversion of T4 to T3 to determine if the deiodination of T4 might
also occur by a ping-pong type mechanism.
Similarities in the subcellular location and catalytic effectors of
the 5'-deiodinase that converts rT3 to 3,3'-T2 and the 5'-deiodinase that
converts T4 to T3 have led to the hypothesis that the same enzyme catalyzes both reactions

(Chopra!!~·,

1978;

Visser!!~·'

1979b).

There

are, however, several findings that do not support a one enzyme theory
such as differences in pH optimum, substrate binding constants and the
in vivo metabolism
--

of T4 and rT3 in the neonate (Maciel et al., 1979).

--

In the present study, kinetic assays were performed with the purified
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iodothyronine 5'-deiodinase to determine if the T4 to T3

con~erting

enzyme also carried out the monodeiodination of rT3 to 3,3'-T2.

CHAPTER II
MATERIALS AND METHODS
Materials
Rat liver tissue was obtained from male and female, Sprague-Dawley
laboratory rats maintained on Purina rat chow and tap water ad libitum.
Groups of from 2 to 10 rats weighing 100-250 g each were anesthetized
with chloroform and exsanguinated by cutting the portal vein and hepatic
artery.

The liver was removed, sliced into small fragments, rinsed in

cold saline (0 °C) and placed into 10 mL vials.

Liver tissue prepared 1n

this manner could be stored 6 months or longer at -60 °C with no effect
on the specific activity of the iodothyronine 5'-deiodinase.

The non-

radioactive substrate !:,-thyroxine (T4), was obtained from Sigma Chemical
Co., St. Louis, MO. as the highly purified free acid, and was used without further purification.

Other substrates, 125r-labeled T4 purchased

from Nuclin Diagnostics, Northbrook, IL., and 125r-labeled reverse T3
(rT3) from AmershamrSearle, Arlington Heights, IL. were purified by
Sephadex G-25 chromatography (Green, 1972) prior to use.
thiol-group-containing cofactors:

The reduced

1-cysteine, glutathione, 2-mercapto-

ethanol, DL-dithiothreitol and DL-6,8-thioctic acid amide (lipoamide)

==

=

were obtained from Sigma.

The inhibitors and related compounds:

methi-

mazole, demamethasone, Q1-propranolol, sodium diatrizoate (Hypaque) and
6-~-propyl-2-thiouracil

(PTU) were purchased from Sigma.

Sodium salicy-

late was obtained from Matheson, Coleman and Bell, Norwood, OH., and iodipamide (Cholografin) was purchased from Squibb and Sons, Princeton, NJ.
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Diethylamineothyl (DEAE) Cellulose (medium mesh), Concanavalin A
(Con A) Sepharose 4B, Sepharose 4B, 6B-CL, Sephacryl S-300 superfine
(sf), Sephadex G-25 medium and Sephadex G-25 superfine were obtained from
Sigma.

Carboxymethyl (CM) cellulose (CM 22) was a product of Whatman,

Clifton, NJ.

The sulfhydryl affinity resin, Affi-gel 401 and the hydro-

xylapatite resin were purchased from Bio•Rad, Richmond, CA.

The organo-

mercurial Sepharose 4B resin was synthesized according to the procedure
of Sluyterman and Wijdeness (1974).
Buffers used throughout the purification of the rat liver iodothyronine 5'-deiodinase included:

homogenate buffer (A) 5 mmol Tris-HCL,

250 mmol sucrose, pH 8.0; homogenate buffer (B) 25 mmol KP04, 50 mmol
NaCl, 1 mmol EDTA, 0.02% NaN3, 10

~ol

2-mercaptoethanol (BME), pH 6.5;

extraction buffer (C) 2 mmol KP04, 10 mmol NaCl, 1 mmol EDTA, 0.02% NaN3,
10 mmal BME, pH 7.5;

column buffer (D) 2 mmol KP04, 10 mmol NaCl, 1 mmol

EDTA, 0.02% NaN3, 10 mmol BME, 0.1 % Nonidet P-40, pH 7.6; elution
buffer (E) same as buffer D except for the content of NaCl which was
increased to 500 mmol NaCl; column buffer (F) Same as buffer D except pH
6.5; elution buffer (G) 500 mmol KP04, 150 mmol NaCl, l mmol EDTA, 0.02

~

M

NaN3, 10 mmol BME, 0.1 % Nonidet P-40, pH 6.5; gel filtration column
buffer (H) 25 mmol KP04, 50 mmol NaCl, 1 mmol EDTA, 0.02 % NaN3, 10 mmol
BME, 0.1 % Nonidet P-40, pH 6.5.
The detergents, Triton X-100 and deoxycholate, and pancreatic lipase were purchased from Sigma.

Nonidet P-40 was obtained from Bethesda

Research Laboratories, Rockville, Md.

A test kit containing the zwitter-

ionic detergents, derivatives of N-hexadecyl-N,N-dimethyl-3-amino-1propane sulfonates, were obtained from Calbiochem Behring Corp., La
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Jolla, CA.
All reagents used for the quantitation of T3 by radioimmunoassy
were of the highest purity commercially available.

Rabbit antisera to T3

was obtained from Endocrine Science Laboratories, Tarzana, CA.
che~Behring

{GARGG).
Sigma.

Calbio-

was the source of goat antibody to rabbit gamma globulin

Non-radioactive 3,3' ,5-triiodo-1-thyronine (T3) was supplied by
125r-labeled T3 with a specific activity of approximately 2400

~Ci/~g

was purchased from Nuclin Diagnostics.

Reagent alcohol (95%

ethanol) was the product of Mallinkrodt, St. Louis, MO.

Human serum

pools were kindly provided by the clinical laboratory of Loyola University Medical Center, Maywood, IL.

Activated charcoal "Norit A" was pur-

chased from Matheson, Coleman and·Bell.
Other reagents:

bovine serum albumin (Cohn fraction V powder),

Coomassie Brilliant Blue G-250, and 3,5'-diiodo-1-thyronine (3,5-T2) were
purchased from Sigma.

Carrier ampholytes (3/10) were the product of LKB

Instruments, Inc., Rockville, MD.

Purified proteins used for the cali-

bration of gel filtration columns were obtained from Pharmacia, Piscataway, NJ.
The following specialized equipment was utilized:

A Potter-

Elvehjem tissue homogenizer (55 mL flask, Kontes Glass Co., Vineland,
NJ.) with the stan-dard teflon pestle (0.007 inch clearance) and

a

pestle

that was turned on a lathe to a clearance of 0.024 inches (Fleischer and
Kervina, 1974).

Dounce homogenizer (40 mL flask; Kontes Glass Co.) with

standard large clearance (A) and small clearance (B) pestles; miracloth
filtration material (Calbiochem); Sorvall Superspeed (RC2-B) refrigerated
centrifuge with the SS-34 rotor (rmin

= 5.72

em, rmax

= 10.80

em);
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Beckman preparatory L5-65 ultracentrifuge with the SW-27 head (rmin
7.53 em, rmax

= 16.12cm);

=

Beckman "Microfuge" (Model 152) with 400 lJL

disposable microtubes (Walter Sarstedt, Inc., Princeton, NJ); Amicon
Corp., Chicago, IL) washed according to the procedure of Brewer (1974),
and stored prior to use at 4 °C in deionized water with 0.02 % NaN 3
as a· bacteriostatic agent; LKB electrofocusing column (110 mL Ampholine
column, #8100); LKB gradient mixer (Model 8121); D.C. power supply
(Buchler Instruments, Fort Lee, NJ); and a TI-59 programmable calculator
with Master Library Module software program (Texas Instruments, Inc.,
Dallas, TX).

Methods
Preparation of Rat Liver Homogenates
Homogenates of the rat liver tissue were prepared with a motor
driven Potter-Elvehjem homogenizer.

The frozen tissue was thawed in 4

volumes of homogenate buffer A or homogenate buffer B and all subsequent
steps were carried out·at 0-4 °C.

The initial tissue disruption was per-

formed with 3 passes of pestle A and cellular homogenization was completed with 3 to 5 passes of pestle B.

The resulting 20 % homogenate was

filtered through a single layer of miracloth to remove unbroken cells and
tissue fragments.
mg protein/mL was

The filtrate (Fraction A), containing approximately 28
st~red

in 10 mL aliquots at -60 oC or used directly as

the source of the iodothyronine 5'-deiodinase for purification studies
and for subcellular fractionation studies.

In Vitro Studies of Thyroxine 5'-Deiodinase Activity
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T4 to T3 converting activity was measured by a modification of
methods described previously (Chopra, 1977a; Maciel~~., 1979; auf dem
Brinke ~~·· 1979).

In summary, aliquots of samples suspected of con-

taining thyroxine 5'-deiodinase activity were incubated with non-radioactive T4 for the time periods given in RESULTS, and the amount of T3
generated was measured by radioimmunoassay (RIA) performed on a ethanol
extract of the incubation mixture.

Under standard reaction conditions,

the following reagents were added in 12 x 75 mm polystyrene culture tubes
in the order given:

1) 320

1 mmol/L EDTA, pH 6.5;

~L

2) 50

in the same buffer; 3) 100

~L

strate solution containing 250
~L

of 150 mmol/L phosphate buffer containing
~L

of 200 mmol/L dithiothreitol, made fresh

of enzyme preparation; 4) 30
~g

T4/mL deionized water.

volume containing 20 mmol/L dithiothreitol, 19.3

~L

of sub-

The final 500

~ol/L

T4, and 0.01-

0.5 mg protein buffered to pH 6.5 was mixed gently by swirling and placed
in a water bath thermostated to 37 °C. The reaction was stopped following
a 30 min incubation (standard reaction conditions) by extraction of the
incubation mixture with 2 volumes (1.0 mL) of 95 % ethanol.

This concen-

tration of ethanol destroyed enzymatic activity completely and afforded a
96-100 % recovery of iodothyronines.

The assay tubes were then tightly

capped, mixed by inversion to facilitate complete extraction of the T3,
and the precipitated protein was pel1eted by centrifugation for 10 min
(1,000 x

£)·

Each assay contained zero incubation tubes (blanks) which

were handled exactly as described above except that the 100

~L

aliquot of

sample was added following incubation and immediately prior to the extraction step.

The T3 content of the blank tubes was considered to re-

present T3 formed from the spontaneous deiodination of T4, T3 contained
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in the commercial T4 preparation, and "apparent" T3 resulting from the
cross-reactivity of T4 in the T3 radioimmunoassay.

The blank varied from

4.5 to 7.2 ng T3/tube when 7.5 Ug T4 was used in the assay.

This value

was subtracted from T3 measured in the test samples to determine the
amount of T3 produced from the enzymatic deiodination of T4.

The results

were expressed in units of activity which were defined as the quantity of
enzyme that transformed 1 pmol T3 per min at 37 °C.
To study the effect of various conditions on 5'-deiodinase activity, changes in standard assay procedure were made as indicated in the
text and Figure legends.

The addition of various agents to the enzyme

assay incubation mixture were made by replacing aliquots of enzyme assay
buffer with equal volumes of solutions containing the test agents.

When

the effects of various salts wera studied, the phosphate buffer was made
up without EDTA.

When studying the effect of various cofactors, solu-

tions of the various sulfhydryl agents were used in place of the dithiothreitol solution.
Kinetic studies on crude and purified preparations of the
deiodinase were

pe~formed

5'-

using standard assay conditions with varying

substrate or cofactor concentrations.

Data were generated under condi-

tions of initial reaction rates and plotted by the method of Lineweaver
and Burk (1934).

For the determination of apparent Km and Vmax were

determined from replots of the primary data (Dixon and Webb, 1979a).
Kr's for the various inhibitors were determined from a replot of apparent
Km or Vmax values determined in the presence of fixed inhibitor concentrations (Lineweaver and Burk, 1934; Dixon and Webb, 1979d).
Enzyme assays performed on samples from the subcellular fraction-

43
ation study were carried out in the absence of detergent.

Unless indica-

cated otherwise, all other assays were done on samples containing 0.1 %
Nonidet P-40.

Sample volumes of 100

~L

were diluted to a final 500

~L

in

the reaction mixture resulting in a final 0.02 % detergent concentration.
This concentration was slightly above the critical micellular concentration (CMC) of 0.017% for Nonidet P-40 (Helenius and Simons, 1975).

For

samples not containing 0.1% Nonidet P-40, detergent was added or samples
were diluted in homogenate buffer B.
Due to the nonlinearity of activity with high protein concentration, serial dilutions of the crude fractions (A through E) were assayed
for 5'-deiodinase activity in order to relate their activity to that of
the more purified fractions.
less"than 5 mg/mL.

Maximum protein concentrations used were

Fraction III and other fractions of high specific

activity were diluted in buffer H to protein concentrations no lower than
0.10 mg/mL.

All enzyme specific activities were based on protein deter-

minations by Coomassie Blue dye-binding (Bradford, 1976) using bovine
serum albumin as the standard.

T3 Radiommunoassay
3,3' ,5'-Triiodo-1-thyronine (T3) quantitation was performed by a
double antibody radioimmunoassay technique very similar to that described
previously for the quantitation of T4
mixtures were pipetted into 400
order:

1) 120

~L

of sample (20

(Collins~~-,

1980).

Reaction

~L

disposable microtubes in the following

~L

of enzyme extract + 100

~1

charcoal

stripped serum); 2) 100 ~L T3 Trace (125I-T3 sufficient to generate
approximately 24,000 cpm/0.1 mL prepared in 100 mmol/L barbital buffer,
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pH 8.6 containing 0.5% bovine serum albumin, 0.5% thimerosal and 0.6 mL
of rabbit serum per 100 mL); 3) 100

~L

T3 Antibody (lyophilized rabbit T3

antiserum reconstituted in the same buffer as used for dilution of T3
Trace with the exception of deletion of rabbit serum; optimal dilution
should allow binding of 45-55 % of the 125t-T3 in the absence of nonradioactive T3); 4) 25

~L

Precipitating Antibody (goat anti-rabbit gamma-

globulin (GARGG) antibody reconstituted according to manufacturers
mendation).

reco~

Following the addition of GARGG, the contents of the assay

tubes were mixed and allowed to incubate for 16 h at room temperature.
The tubes were then centrifuged for 2 min (10,000 x £) in a Beckman
microcentrifuge to precipitate the bound hormone complex, and the unbound
hormone was removed by aspiration.

The cpm of 125t-T3 remaining in the

precipitant were determined. by counting each tube in an automatic gamma
counter for a period of 60 sec.

T3 Standards (0,25,50,75,100,150,200,-

300,500 and 600 ngT3/100 mL) were made up in charcoal stripped serum and
were run with each assay by replacing the 100
serum in step (1) with 100

~L

~L

of charcoal stripped

of the respective T3 Standard.

In a like-

wise manner, control pools were assayed to determine inter-and intraassay variation.

A total counts tube, consisting of 100

~L

T3 Trace, and

a nonspecific binding (NSB) tube, set up as described above using barbital buffer in the place of T3 Antibody for the zero T3 standard, were
also added to each assay.

Data for the standard curve were linearized in

the form of a logit-log plot (Rodbard
59 programmable calculator.

!!~·'

1968) with the use of a TI-

The NSB (<S %) and the precision (inter-

assay and intra-assay coefficients of variation <8 %) compared favorably
to that reported previously

(Collins!!~·,

i980).
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Extracts of the enzyme assay containing 63.3 % ethanol were added
to the RIA incubation mixture in 20

~L

aliquots.

This volume resulted in

a final 3.7% concentration of ethanol and resulted in an increase in the
slope of the standard curve of from -2.6 to -2.4.

In order to minimize

the effects of ethanol on measurements of T3 by the RIA procedure, 20

~L

aliquots of the incubation mixture were consistently used through-out
this study, and 20

~L

aliquots of 63 % reagent alcohol were added to

standard and control tubes as described.

Since the ethanol extract con-

tained little or no protein, as evidenced by a lack of precipitant in the
presence of 10 % trichloroacetic acid, use of 63 % reagent alcohol alone
to treat the standards and controls was considered sufficient to. render
the unknowns comparable to the standards (Chopra, 1977a).

The presence

of Nonidet P-40 in the ethanol extract (0.0067 %) resulted in a final
detergent concentration of 0.0004 % ~n the RIA mixture, and was found not
to have a significant effect on the performance of the radioimmunoassay.
Any effects of other non-T3 substances on the RIA were taken into account
by measuring T3 in the zero-incubation (blank) tubes.
The sensitivity of the assay varied from 15 to 25 pg T3 per tube,
as determined by the amount of T3 required to reduce the number of cpm of
the zero standard by 10 %.
ng T3

~n

This allowed detection of as little as 1.35

the enzyme assay incubation mixture.

small fraction (0.02 %) of the 7.5

~g

This amount was a very

T4 added per enzyme assay.

Subcellular Fractionation
Subcellular fractions of the rat liver homogenate (Fraction A) were
prepared by the method of Aronson and Touster (1974), with slight modifi-
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cation.

Fraction A, suspended in homogenate buffer A, was centrifuged at

1,000 x £for 10 min.

The supernatant was removed by pipette and the

pellet was rehomogenized in buffer A.

This step was repeated twice and

the three supernatants were combined and designated as the cytoplasmic
extract (Fraction E).

The washed pellet, resuspended in 57% sucrose,

was labeled as the nuclear fraction.

In order to sediment the nuclei,

the nuclear fraction was centrifuged at 33,000 x £for 7.5 min.

Follow-

ing centrifugation, the supernatant fluid was removed by aspiration and
the fluffy, dark brown material layered over a small firm pellet of tan
material was decanted.

This dark brown material was suspended in 3

volumes of 57% sucrose and labeled as Fraction N (nuclei).
natant and the tan pellet were discarded.

The super-

The cytoplasmic extract (Frac-

tion E) was also centrifuged at 33,000 x £for 7.5 min to obtain the
mitochondrial and lysosomal pellet (Fraction M + L).

The remaining

33,000 x £ supernate was centrifuged at 78,000 x £ for 100 min.

The

resulting pellet, resuspended in 4 volumes of 57 % sucrose, was labeled
as Fraction P (microsomal fraction).

The 78,000 x £supernatant was

labeled as Fraction H (cell cytosol).
Plasma membrane fractions were obtained from the nuclei (Fraction
N) and microsomal (Fraction P) preparations by high speed centrifugation
in a discontinous sucrose gradient according to the procedure of Avonson
and Touster, 1974.

In short, 15-18 mL of the suspended crude nuclei (N)

or i3-15 mL of the crude microsomes (P) were placed in the bottom of cellulose nitrate centrifuge tubes for the Beckman SW-27 rotor.

Fifteen

milliliters of 37.2 % sucrose were then carefully layered over the nuclei
sample without mixing of the layers, and a third layer of 250 mmol/L
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sucrose was added in the same manner for a total volume of 38.5 mL.

On

the microsomal fraction were layered 17 mL of 34 % sucrose and a layer of
250 mmol/L sucrose to a final volume of 38.5 mL.

The discontinuous gra-

dients were then centrifuged at 75,500 x £ (24,000 rpm) for 16 h.

The

electronic brake was used to decelerate the rotor at the end of the run.
Fractions from each run were collected.
from the nuclei:

Four fractions were obtained

The first, a layer of congealed fat (Nl), floated at
A plasma membrane band (N 2 ) consisting of small

the top of the gradient.

pieces of a tan material appeared at the interface of the 250 mmol/L and
37.2 % sucrose layers.
tion.

The 37.2 % layer was removed as the third frac-

This band (N3) was reported to consist of mitochondria and seg-

ments of plasma membrane.
the final fraction (N4).
microsomal material:

The bottom portion containing the nuclei was
Four fractions were also obtained from the

The first, a layer of congealed fat (Pl) floated at

the top of the gradient.

The plasma membrane fraction (P2), a thick band

of white material, formed at the interface between the 250 mmol/L and 34

% sucrose layers.

The 34 % sucrose layer (P3) appeared faintly cloudy

and contained a mixture of plasma membranes and microsomes.

The micro-

somal membrane fraction (P4) appeared at the top of the 57 % sucrose sample layer.
All resuspensions, following centrifugation steps, were done with
the aid of a Dounce type tissue homogenizer.

Homogenization was accom-

plished with from 2 to 4 complete strokes of the "A" pestle through the
homogenate suspensions.

All steps were carried out at 0-4 °C.

flasks were pre-chilled on crushed 1ce.

Buffer

The homogenate solutions were

kept on ice at all times except during centrifugation steps which were
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carried out in refrigerated centrifuges.

All sucrose solutions were made

in 5 mmol/L Tris buffer and titrated to pH 8.0 (23 •c) with 1 mol/L HCL
prior to their final dilution.
trations by refractometry.
Seitz refractometer at 25
centrations given.

Buffers were checked for sucrose concen-

The percent sucrose, as read directly from a

•c,

was determined to be ± 0.05 % of the con-

The complete separation procedure required approxi-

mately 48 hours from start to finish and aliquots saved from each fraction were dialyzed against a 10-fold dilution of buffer B prior to protein quantitation and enzyme activity studies.

All enzyme assays were

run concurrently to determine the relative specific activity of thyroxine
5'-deiodinase in each fraction.

Preparation of Crude Rat Liver Membranes
Fraction A homogenate prepared in buffer B and stored frozen in 10
ml aliquots for up to 6 months at -60 oC was thawed rapidly in a 37 °C
water bath with continual agitation.
vials were placed in ice water.
fuged at 37,000 x

~

Just prior to complete thawing, the

The thawed homogenate was then centri-

for 1 h in a Sorvall SS-34 rotor.

tion B) was decanted and saved for further analysis.

The cytosol (FracThe firm light

brown membrane pellet and a clear yellow gel at the bottom of the centrifuge tube were resuspended in homogenate buffer B to initial volume and
centrifuged a second time at 37,000 x

~for

1 h.

Following the second

centrifugation, the clear supernate was discarded and the crude membrane
pellet was resuspended
labeled as Fraction C.

~n

initial volume in extraction buffer C and
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solubilization of Iodothyronine 5'-Deiodinase
Several extraction techniques were attempted 1n preliminary studies
to achieve a selective solubilization of the rat liver iodothyronine 5'deiodinase from Fraction C.

These techniques were performed according to

commonly used membrane extraction procedures (Morton, 1955; Penefsky and
Tzagoloff, 1971) and included:

acid and alkali extraction, freezing and

thawing, extraction with organic solvents

(~-butanol

and ethanol), enzy-

matic digestion with pancreatic lipase, and detergent solubilization with
deoxycholate, zwittergents (sulfobetaines), Triton X-100, and Nonidet P40.

A description of the conditions utilized is given in the text and

figure legends of the Results section.

The method chosen in the present

study for solubilization of the membrane bound 5'-deiodinase was solubilization with Nonidet P-40.

All steps

w~re

carried out at 0-4 °C.

Commercially prepared Nonidet P-40 (NP-40) was used without further
purification and a 10 % working solution was prepared by diluting the
commercial reagent with deionized water.

This solution could be kept for

several weeks at room temperature without the formation of a precipitate.
Solubilization of T4 S'-deiodinase activity was carried out in two
steps.

In the first step, NP-40 was added to Fraction C in a dropwise

manner with stirring to a final concentration of 0.05 %.

The detergent-

membrane mixture was stirred for an additional 10 min, and homogenized 1n
the Dounce homogenizer with 10 complete strokes of pestle A, and 2
strokes with pestle B.

The suspension was then centrifuged at 37,000 x

for 1 hr in the Sorvall centrifuge with the SS-34 rotor.
40 extract (Fraction

c2 )

~

The 0.05 % NP-

was removed by pipette and discarded, and the
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remaining membrane (Fraction Cl) was resuspended Ln 4 volumes of buffer

c.

In the second step, NP-40 was added to Fraction C1 to a final concen-

tration of 0.7 %.

Addition of the detergent, homogenization, and centri-

fugation were repeated as described in step 1.

The resulting supernatant

(Fraction D) containing the 0.7% NP-40 membrane extract was decanted.
This light brown, slightly opaque solution was used fresh for further
purification of the 5'-deiodinase or stored in capped vials in 10 mL aliquots at -60

•c.

When stored in this manner, Fraction D could be kept

for up to 1 month with little or no loss of catalytic activity.

The

remaining unsolubilized membrane (Fraction E) was discarded.
The quantity of detergent solution (B mL) added in the second step
was calculated from the following formula with the aid of a Texas Instru-

(:~)·
B

A •
(

A

a%)

b%

= ----------------------c%)

1 - ( b%

ments TI-59 programmable calculator.
formula:

(A mL • a%) + (B mL • bi.)

that A + B

= C.

The equation was derived from the

=

(C mL • ci.), with the assumption

The terms are defined as follows:

A= mL homogenate; B

= mL detergent to be added (unknown); and C = mL of final volume (un-

known).

The small case letters (a, b, anc c) represent

concent~ations

of

the extract already or to be added to each of the respective solutions.

Purification of Nonidet P-40 Solubilized Iodothyronine 5'-Deiodinase
Purification techniques attempted but not used in the procedure for
the purification of the Fraction D 5'-deiodinase included:

salt frac-
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tionation with ammonium sulfate (Weir, 1973), and fractionation with
polyethylene glycol (Chesebro and Svehag, 1968).

A 5-fold dilution of

Fraction D, was used for cationic exchange cellulose chromatography with
carboxymethyl (CM) cellulose (Wharton and McCarty, 1972), affinity chromatography with Affi-Gel 401

(Brocklehurst~~.,

1974), and

organomercurial-Sepharose 4B (Sluyterm and Wijdenes, 1974) and lectin
binding chromatography with Concanavalin A-Sephrose 4B (Norden and
O'Brian, 1974).

These techniques were performed on Fraction Din buffer

C as previously described, with minor modifications.

All steps were

carried out at 4 °C with the exception of Concanavalin A column elution
which was performed at room temperature.
or on ice prior to

dete~ination

All samples were stored at 4 °C

of enzyme catalytic activity.

Concen-

trations of reagents used, and a description of the effectiveness of each
technique are given in the Results section.
DEAE Cellulose chromatography was performed for the initial purification of the Fraction D preparation.

DEAE Cellulose was prepared fresh

or regenerated after previous usages by the method of Brewer (1974).

A

2.4 x 14 em column of cellulose, equilibrated in buffer D, having a bed
volume of 55 mL was prepared at least 16 h prior to use.

Fracti0n D in a

20-25 mL aliquot containing from 350 to 400 mg of protein was applied to
the cellulose column at a flow rate of 40 mL/h.

Following addition of

the enzyme preparation, the column was washed with buffer D until the
A280 dropped to base line.
bed volumes of buffer D.

Typically, this required approximately 3 to 4
Elution of the bound protein was performed

~n

either a stepwise manner or with a linear gradient by increasing the concentration of salt in buffer D from 10 to 500 mmol/L NaCl.

Individual
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fractions were divided into 3 pools:
eluted with the sample front.

Pool 1 contained the proteins that

Pool 2 (Fraction I) contained the majority

of the 5'-deiodinase, and consisted of those fractions collected following the initial drop of Azgo, but prior to the addition of NaCl.

Pool 3

was the NaCl eluted protein.
Fraction I from the cellulose chromatography step was added in a
ratio of 3.4 mg protein :

1 mL hydroxylapatite gel to a beaker and stir-

red slowly (to avoid foaming) for 16 h.

Following the batchwise adsorp-

tion, the hydroxylapatite gel was recovered by centrifugation of the
slurry at 1,000 x

£

for 10 min, and the recovered hydroxylapatite was

poured into a 2.4 x 16 em column for column chromatography.
was washed with

buffe~

The column

F at a flow rate of 20 mL/h until the effluent was

free of protein and then eluted with a step gradient of increasing KHzP04
concentration.

The step gradient was made by diluting buffer G with buf-

fer F to give solutions of:

50, 125, and 400 mmol/L KH 2 Po4.

Approxi-

mately 5 bed volumes of each elution buffer were applied to the column
and the fractions collected at a concentration of 125 mmol/L phosphate
were pooled together for the Fraction II enzyme preparation.
A Sephadex G-25 gel filtration column (2.6 x 90 em) equilibrated
buffer F was used to desalt Fraction II.

~n

Sample volumes of up to 65 mL

were applied to the 300 mL bed volume column at a flow rate of 70 mL/h,
and the effluent fraction containing 5'-deiodinase activity were pooled
and concentrated on a mini-column (3 mL bed volume) of hydroxylapatite
equilibrated

~n

buffer F.

The desalted enzyme solution was applied at a

flow rate of 12 mL/h, and the adsorbed protein was recovered with a 300
mmol/L phosphate elution buffer at a flow rate of 4 mL/h.

This technique
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allowed the partially purified enzyme to be recovered in a volume of
approximately 6 mL.
A Sepharose 6B-CL gel filtration column (1.5 x 98.5 em) was used
for the third step in the purification sequence.

Fraction II concentrate

was applied to the column in 3 to 6 mL aliquots, and chromatography in
buffer H was performed at a flow rate of 20 mL/h.

Fractions were col-

lected and assayed for thyroxine 5'-deiodinase activity.

Those fractions

containing high concentrations of activity were pooled and labeled as
Fraction III.

This fraction was stored in tightly closed vials at 4 °C

prior to use in characterization studies.

Isoelectric Focusing

-

Isoelectric focusing of the Fraction III iodothyronine

5'-deiodi-

nase was performed at 4 °C in a 110 mL electrofocusing column mounted
a vertical position.

~n

When the cathode was used at the bottom of the

column the column was prepared in the following manner:

12.5 mL of the

cathode buffer were added into the center chamber of the column.

The LKB

gradient mixer was used to develop the sucrose gradient as 55 mL of the
heavy gradient solution and 55 mL of the light gradient solution, containing the protein sample were added to the column.

Following the addi-

tion of the sucrose gradient, 12.5 mL of the anode buffer were added to
the top of the gradient.

Electrophoresis was begun, following the re-

lease of the cathode chamber plug, by adjusting the power source to deliver an initial output of 200 v.

The voltage was gradually increased to

400 v keeping the wattage below 1.5 watts throughout the run.
tage was increased to 350 v after 10 h and to 400 v after 19 h.

The vo1The
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column was developed an additional 26 h at 400 v.

Prior to turning off

the voltage, the amperage had stabilized to 1.4 ma for 3 h.

The plug was

used to close off the cathode chamber and the column was eluted.
The sucrose gradient was eluted at a rate of 2 mL/min with the aid
of a peristaltic pump.

The column effluent was collected in 1.5 mL frac-

tions and immediately following the collection of the effluent, the individual fractions were covered with Parafilm and placed on ice.

The pH of

each fraction was measured with a digital pH meter standardized with buffers at 0-4 °C.

The protein concentration and activity of the iodothy-

ronine 5'-deiodinase were also determined for each fraction.

Reagents for Isoelectric Focusing:
~L

of 10 % Non-

100

~L

of 85 % phosphoric acid, 125

idet P-40, and 625

~L

of 100 mmol/L dithiothreitol were diluted to

Anode Buffer.

12.5 mL with deionized water.
Cathode Buffer.

5.725 g sucrose, 1.25 mL of 10% NaOH, 125

Nonidet P-40, and 625

~L

~L

10%

of 100 mmol/L dithiothreitol were diluted

to 12.5 mL with deionized water.
Light Gradient Solution.
1.25

10 mL of protein sample (Fraction III),

mL of ampholytes (3/10), 0.6 mL of 10% Nonidet P-40, and 3.0

mL of 100 mmol/L dithiothreitol were dissolved in deionized water
and diluted to a final volume of 60 mL.
Heavy Gradient Solution.

28.0 g sucrose, 3.75 mL ampholytes

(3/10), 0.6 mL 10% Nonidet P-40, 3.0 mL of 100 mmol/L dithiothreitol were diluted to a final volume of 60 ml with deionized
water.
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Molecular Weight Determination
The apparent molecular weight of the detergent solubilized iodothyronine 5'-deiodinase was approximated by analytical gel filtration
chromatography.

A Sephacryl S-300 superfine column (1.5 x 98.4 em) was

calibrated with the Pharmacia low molecular weight and high molecular
weight calibration kits according to manufacturers recommendations.
following protein standards were used:

The

ribonuclease A (13,700 daltons),

chymotrypsinogen A (25,000 daltons), ovalbumin (43,000 daltons), bovine
serum albumin (67,000 daltons), aldolase (158,000 daltons), catalase
(232,000 daltons), ferritin (440,000) daltons), and thyroglobulin
(669,000 daltons).
volume.

Blue dextran 2,000 was used to determine the void

Chromatography of both protein standards and enzyme preparations

was performed in column buffer H (4 °C) at a rate of 12 mL/h.

Gel fil-

tration chromatography with the above standards was also performed on a
Sephadex G-200 column (1.5 x 96 em) and the Sepharose 6B-CL column (1.5 x
98 em).
The approximate molecular weight of the iodothyronine 5'-deiodinase
was determined from a plot of the log molecular weight versus the Kav of
each standard.

The Kav was determined from the equation Kav

=

(Ve -V0 ) /

(Vt -V0 ); where Ve is the elution volume for the protein, V0 is the void
volume as determined by blue dextran, and Vt is the total bed volume of
the gel.

In addition to relating the elution volume of the enzyme to the

protein standards to determine an approximate molecular weight for the
enzyme, a plot of -log Kav versus the Stokes' radius was also used to
approximate the molecular size of the solutilized enzyme.
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Enzymatic Assays With 125r-T4 and 125I-rT3 Substrates
The 5'-deiodination of 125I-labeled T4 and rT3 by the Fraction D
and Fraction III enzyme preparations was carried out under standard
enzyme assay conditions with the exception that the pH for the deiodination of rT3 was increased to pH 7.5 and the addition of radiolabeled substrates were added to the incubation mixture.

The T4 and rT3 substrate

solutions contained 6.5 ~g T4 + 0.0572 ~Ci l25I-T4/100 ~L and 5.0 ~g rT3
+

0.0092 ~Ci 125I-rT3/100 ~L, respectively.

Prior to use, the radio-

labeled substrates were purified by Sephadex G-25 column chromatography
according to the method of Green (1972).
the addition of 50

~L

The reaction was stopped with

of a solution containing 2 mol/L NaOH and 5 mol/L

NaCl rather than 1.0 mL of the reagent alcohol.
pH of 12.5 or higher.

This resulted in a final

The percent 125I-T4 and 125I-rT3 deiodinated was

determined by separating the substrates and products of the reaction mixture by Sephadex G-25 column chromatography (Green, 1972;

Burman!!~·'

1977) and counting the radioactivity in each of the peaks.
Sephadex G-25 chromatography was performed in 0.8 x 19 em columns
(10.0 mL bed volume) at a flow rate of approximately 20 mL/h.

The sample

was added in a solution having a final concentration of 0.015 mol/L NaOH,
0.5 mol/L NaCl.

The column buffer was 0.1 mol/L NaOH, 0.005 mol/L NaCl.

A sample volume of 400
were collected.

~L

was applied and fraction volumes of 1.03 mL

The void volume was 5.0 mL.

Free iodide (125I) eluted

1n a sharp peak (8-12 mL) with an elution volume Ve of 10.0 mL.

l25r-T3

and the rT3 metabolite (3,3'-T2) eluted in a sharp peak (15 to 20 mL)
with a ve of 17.0 mL.

125I-T4 and 125I-rT3 eluted 1n a broad peak (22-30

mL) with a Ve of 25.5 mL.

A single column run required approximately 90
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min to complete.

The columns demonstrated excellent reproducibility and

sample recovery was essentially complete.

CHAPTER III
RESULTS
Subcellular Fractionation
The subcellular distribution of iodothyronine 5'-deiodinase in rat
liver cells was studied by differential centrifugation as described in
METHODS.

The results are presented in Table 2.

found in all fractions studied.

Deiodinase activity was

The fraction with the least amount of

activity was the 78,000 x £supernatant.

Of the particulate enzyme

fractions, the greatest concentrations of 5'-deiodinase activity were
found in the crude microsomal and crude nuclear fractions.
The crude microsomal fraction (Fraction P) and the crude nuclear
fraction (Fraction N) were further subdivided by ultracentrifugation in a
discountinuous sucrose gradient.

When the resulting plasma membrane sub·-

fractions were assayed for 5'-deiodinase activity, it was found that

t~e

deiodinase was distributed throughout the membrane fractions rather than
being predominately associated with any one fraction.

The subfraction

with the greatest yield of deiodinase activity was the microsomal enriched fraction (Fraction P4) which had a 30 % yield of 5'-deiodinase
activity and a 2.5-fold increase Ln specific activity.
% of the deiodinase activity was recovered 1n Fractions:

P3, as shown in Table 2.

An additional 38
N2, N3, P2 and

The subfractions of greatest specific activity

were the plasma membrane fractions (N2) and (P2) and the endoplasmic
reticulum enriched plasma membrane fraction (P3), which had relative
specific activities of 6.1, 6.8, and 10.1, respectively.
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Table 2
Distribution of Iodothyronine 5'-Deiodinase Activity Following
Subcellular Fractionation of Rat Liver Homogenate

FRACTION
(N)

Nuclei
(1,000 x £pellet)

(M + L) Mitochondria plus
Lysosomes (33,000 x g
pellet)
-

5 '-DEIODINASE
PROTEIN
ACTIVITY
(% of total) (% of total)

RSA*

(n)**

17.6 ± 4.3

30.5 ± 6. 0

1.73 ± 0.62

6

15.2 ± 2.8

13.4 ± 4.1

0.88 ± 0.28

6

(P)

Microsomes
( 78,000 X£ pellet)

14.1 ± 2.8

48.2 ± 8.7

3.42 ± 1.03

6

(S)

Cytosol
(78 ,000 x £ supernate)

48.0 :f 3. 7

6.8 ± 3.1

0.14 ± 0.03

9

Recovery From Homogenate:

94.9 ± 8

98.9 ± 14

(N2)

Plasma Membrane (pm)

1.7

10.3

6.1

2

(N3)

pm + Mitochondria

7.6

9.1

1.2

2

(N4)

Nuclei

8.2

8.8

1.1

2

17.5

28.2

Recovery From Fraction N:
(P2)

Plasma Membrane

1.2

8.2

6.8

2

(P3)

pm + Endoplasmic
Reticulum

1.0

10.1

10.1

2

(P4)

pm + Microsomes

11.9

29.5

2.5

2

14.1

47.8

Recovery From Fraction P:

Data are mean ± standard deviation, or the average of duplicate
determinations.
* RSA = Relative Specific Activity (RSA of the crude homogenate = 1.0).
** (n) = number of fractionation runs.
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Solubilization of Iodothyronine 5'-Deiodinase
Results from the subcellular fractionation study indicated that the
iodothyronine 5'-deiodinase was primarily a particulate enzyme and,
therefore, that membrane extraction would be required prior to purification.

A crude membrane preparation (Fraction C) was used as the start-

ing material and several techniques for the solubilization of the

51-

deiodinase were evaluated.
Two physical methods were attempted to extract the enzyme.

Exten-

sive membrane homogenization with Potter-Elvehjem or Dounce homogenizers
did not increase the yield of soluble 5'-deiodinase activity significantly.

When Fraction C was subjected to 8 freeze-thaw cycles, 10 %or

less of the total particulate activity was extracted.
A number of chemical extraction techniques were also investigated.
Acid

~xtraction

failed to solubilize the 5'-deiodinase and at pH's below

5.8 resulted in a sharp decrease in recoverable particulate activity.
Alkali treatment also failed to extract the enzyme, and resulted in a
more gradual decrease in the recovery of particulate activity.
c~ease

were

became more prominent above pH 7.8.

~ffective

This de-

Neither n-butanol nor ethanol

in extracting active enzyme from Fraction C when solvent

concentrations of from 0.1 %to 5.0% were tested.

The enzyme was comr

pletely inactivated by extraction at 4 °C with concentrations of
butanol greater than 4.0 %.

n-

The inactivation of the enzyme during etha-

nol extraction at 4 °C was less severe, but still approached 50 % at an
ethanol concentration of 5.0 %.
Enzymatic digestion of Fraction C with pancreatic lipase
0.16% did not extract protein or 5'-deiodinase activity.

(0.02-

At a lipase
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concentration of 0.32 %, approximately 20 % of the protein content of
Fraction C was released.

Higher concentrations of lipase released

greater amounts of protein, however, 5'-deiodinase activity was not observed in the lipase extracts at any of the concentrations tested.
Detergent solubilization of the crude membrane preparation with the
a~ionic

detergent, deoxycholate (DOC); the nonionic detergent, Triton X-

100 (TX-100); Nonidet P-40 (NP-40); and zwittericnic detergents (Zwittergents:

3-08, 3-10,· 3-12, 3-14, and 3-16) was also evaluated.

The solu-

bilization of the crude membrane preparation to clarity with the dropwise
addition of a 10 % solution of DOC resulted in a complete loss of deiodinase activity.

A partial reactivation of the 5'-deiodinase could be

achieved by removing DOC via Sephadex G-25 filtration, however, the yield
of solubilized enzyme activity from Fraction C was less than 16 % using
this technique.

When DOC concentrations of 0.18, 0.30, 0.60, and 0.80%

were used the yields of solubilized activity were:
respectively (assayed in the presence of DOC).

18, 24, 8, and 2 %,

The solubilization of

Fraction C with several nonionic and zwitterionic detergents at final
detergent concentrations of 0.3 % gave the following results when enzyme
assays were carried out in the presence of the solubilizing detergent:
Triton X-100 solubilized 64 % of the protein and 30 % of the deiodinase
activity, NP-40 solubilized 68 % of the protein and 41 % of the deiodinase activity, and the Zwittergents:

3-08, 3-10, 3-12, 3-14, and 3-16

solubilized 35, 55, 70, 80, and 53 % of the protein respectively and 4,
22, 28, 14, and 16 % of the deiodinase activity respectively from Fraction C.

Further experiments using combinations of DOC and NP-40, and

combinations of the Zwittergents and NP-40 did not increase the yield of
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solubilized 5'-deiodinase.
Based on the results of the extraction techniques presented above,
detergent solubilization with NP-40 was chosen as the most suitable
method for the extraction of active iodothyronine 5'-deiodinase from
crude rat liver membrane preparations.

To determine the conditions

necessary to selectively solubilize the 5'-deiodinase, further experiments were conducted to study the effect of detergent concentrations on
membrane solubilization.

The results are presented in Figures 6 and 7.

Homogenization of Fraction C with 0.05 % NP-40 solubilized 55 % of the
protein and 4.6 %of the 5'-deiodinase activity.

Protein solubilization

reached a plateau above 0.4% detergent and solubilization with 0.7%
detergent extracted 78 % of the protein from Fraction C and resulted in a
60% yield of solubilized 5'-deiodinase activity.

The apparent inactiv-

ation of the total 5'-deiodinase activity in the presence of increasing
concentrations of detergent (Figure 7) could not be reversed by detergent
removal and, therefore, limited the maximum yield of solubilized enzyme
activity to approximately 60 % of that present in Fraction C.
Other experiments demonstrated that the yield of active 5'deiodinase was dependent on the pH of the extraction buffer.

The optimum

pH for solubilization with NP-40 was found to be in the range of pH 7.0
to 7.5.

Purification of Iodothyronine 5'-Deiodinase
Preliminary experiments were performed to evaluate several purification techniques as to their potential usefulness in the purification of
the crude NP-40 solubilized deiodinase (Fraction D).

These techniques
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Figure 6. Effect of Nonidet P-40 concentration on the solubilization of
protein from rat liver membranes.

Varying quant~t~es of detergent were .added (4 °C) in a dropwise
manner with stirring to.a sample of Fraction C containing 65 mg of protein. The final volume was adjusted to 10 mL with homogenate buffer (pH
7.35), and the mixture was homogenized in the Dounce homogenizer with 12
strokes of pestle A. The soluble protein was separated from the pellet
following centrifugation (37,000 x g, 45 min). The solubilized protein
(o), unsolubilized protein (£0 and total protein (e) are plotted as a
function of Nonidet P-40 concentration. Data are the averages of duplicate determinations.
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Figure 7. Effect of Nonidet P-40 concentration on the solubilization of
iodothyronine 5'-deiodinase activity from rat liver membranes.

Varying quant1t1es of detergent were added (4 °C) in a dropwise
manner with stirring to a sample of Fraction C containing 63 mg of protein. The final volume was adjusted to 10 mL with homogenate buffer (pH
7.35), and the mixture was homogenized in the Dounce homogenizer with 12
strokes of pestle A. The solubilized protei~s were separated from the
pellet following centrifugation (37,000 x g, 45 min). T4 to T3 converting activity in the solubilized extracts tO) and in the pellet ~ was
determined by standard 5'-deiodinase assay conditions (See MATERIALS AND
METHODS). The detergent concentration for all samples was adjusted to
0.1 % NP-40 prior to enzyme assay. Total activity (e) is the sum of
solubilized and pellet activities. Data are the averages of duplicate
determinations.
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included.affinity chromatography, ion exchange chromatography, chromatography using.hydroxylapatite, gel filtration chromatography and fractionation with ammonium sulfate and polyethylene glycol.

Additional experi-

ments were also performed to evaluate methods for desalting and concentrating solutions of the enzyme.
When the crude NP-40 solubilized preparation was applied to a column of Concanavalin A-Sepharose 4B, 88 % of the 5'-deiodinase and 93 % of
the protein passed through the column unadsorbed.

Elution of the column

with 750 mmol/L alpha-methyl-mannoside resulted in the recovery of the
remaining 7 % protein, but no additional 5'-deiodinase activity.
total recovery of 5'-deiodinase was 88 %.

The

In experiments using an Affi•

Gel 401 sulfhydryl-binding affinity column, an average 72 % of the applied enzYme and 97 % of the applied protein was recovered in the unbound
fraction.

An additional 3-8 %of the 5'-deiodinase and the remaining 3 %

protein was recovered by elution with SO mmol/L 1-cysteine.

The total

recovery of 5'-deiodinase activity from the Affi•Gel column was approximately 77 %.

When an organomercurial Sepharose 4B resin was used as a

sulfhydryl-binding adsorbent, approximately 18 % of the applied deiodinase and 56 % of the applied protein did not bind to the column.

-

the column was eluted with 50 mmol/L L-cysteine, 25 % of the
deiodinase activity and 44 % of the protein were recovered.
recovery of 5'-deiodinase activity was 43 %.

When

5'The total

A similar yield of enzyme

activity and protein were obtained when the organomercurial column was
eluted with 25 mmol/L dithiothreitol.
Both cation and anion exchange celluloses were used to evaluate ion
exchange chromatography of the crude NP-40 solubilized 5'-deiodinase.
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During cation exchange chromatography of Fraction D on CM cellulose equilibrated to pH 6.4, the unadsorbed protein eluted from the column in an
initial sharp peak containing 64 % of the deiodinase activity and 70 % of
the protein.

A second smaller peak of unadsorbed protein trailed behind

the first and contained an additional 18 % of the deiodinase and 22 % of
the protein from the applied sample.

Elution of the adsorbed protein

with 350 mmol/L NaCl resulted in the recovery of 6 % of the enzyme and 8
% of the protein.

The total recovery of protein was 98 %, and the total

recovery of enzyme activity was 88 %.

Elution with increased concentra-

tions of NaCl failed to recover additional activity from the column.
Chromatography at pH's less than 6.4 resulted in decreased recoveries of
enzyme activity due to the tendency of the detergent solubilized 5'deiodinase to precipitate under acidic conditions.
Anion exchange chromatography was performed using DEAE cellulose.
Maximum recovery of enzyme activity occured when the column and sample
were equilibrated to pH 7.6.

The majority of the unadsorbed protein

eluted from the DEAE cellulose column

~n

a sharp peak containing approxi-

mately 20-30 % of the applied protein and 10-30 % of the applied deiodinase.

Following the initial peak of unadsorbed protein, small amounts of

protein eluted as the column was washed with buffer.

This trailing peak

contained 8-15 %of the applied protein and 50-65 % of the applied 5'deiodinase activity.

In a typical run, 20 % of the applied enzyme and 65

% of the applied protein adsorbed to the column matrix.

When a linear

gradient of increasing NaCl concentration was then applied to the column,
additional 5'-deiodinase activity eluted from the column in amounts proportional to the peaks and troughs of the total protein elution pattern.
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The largest peak of 5'-deiodinase activity was eluted at a NaCl concentration of 100 mmol/L.

The specific activity of this peak was calculated

to be 0.12 relative to 1.0 for the crude Fraction A, and 1.29 for the applied sample.

In a typical run, the total recovery of protein was ap-

proximately 100 %, and the total recovery of deiodinase activity was in
the range of from 120-130 %, suggesting that a mild activation of the 5'deiodinase occured during the DEAE cellulose step.
Further experiments with DEAE cellulose demonstrated that the 5'deiodinase had a low affinity for the diethylaminoethyl ligand of the
cellulose matrix at pH 7.6.

When a previously adsorbed peak was pooled,

desalted, and reapplied to DEAE cellulose, 43 % of the enzyme and 86 % of
the protein readsorbed.

The remainder of the sample eluted in a single

broad peak with the low ionic strength column buffer.

When the unad-

sorbed activity was pooled and reapplied, an additional 4 % of the enzyme
and 9 % of the protein adsorbed to the DEAE cellulose.
Addition of the crude NP-40 solubilized membrane extract to a hydroxylapatite column resulted in the adsorption of 94 % of the applied
enzyme and 72 % of the applied protein.

Elution of the adsorbed enzyme

from the hydroxylapatite column with a linear gradient of increasing
phospage concentration, resulted in a broad wavy peak of 5'-deiodinase
activity which coincided with the bulk of the eluted protein.

In a simi-

lar manner, elution of the enzyme from the hydroxylapatite column with a
step gradient resulted in elution of enzyme activity over a broad range
of phosphate concentrations in such a manner that there was no significant increase in specific activity for any of the peaks obtained.

A sin-

gle sharp peak of activity could be recovered from the hydroxylapatite
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column, however, when the applied sample had been previously purified by
DEAE cellulose chromatography.

Elution of the partially purified

5'-

deiodinase from the hydroxylapatite column with a linear phosphate gradient resulted in the recovery of 76 % of the applied enzyme within a concentration range of 90 to 150 mmol/L phosphate.
purified enzyme with a step gradient of:
phosphate resulted in the recovery of:

Elution of the partially

100, 150, 200 and 300 mmol/L
49.3, 19.9, 11.3, and 15.5 %, re-

spectively of the applied enzyme activity and 11.1, 16.9, 24.4, and 21.0

%, respectively of the applied protein.

The 100 mmol/L

resulted in a 4.4-fold increase in specific activity.

phosphat~

step

Approximately 24 %

of the protein and 4 % of the enzyme did not adsorb to the hydroxylapatite column.
Gel filtration chromatography of the crude NP-40 solubilized membrane extract was performed on columns of Sephadex G-100 and Sepharose
6B-CL.

When the detergent extract was added to Sephadex G-100, and chro-

matographed in the presence of detergent, 98 % of the deiodinase activity
and 42 % of the protein from the sample eluted 1n the void volume.

The

included volume contained 58 % of the sample protein and no deiodi3ase
activity.

When the detergent extract was applied to Sepharose 6B-CL, 6 %

of the deiodinase eluted in the void volume, 11 % eluted as a large molecular weight complex in excess of 400,000, and 54 % was recovered in a
symmetrical peak corresponding to an average molecular weight of 280,000.
The total recovery of 5'-deiodinase activity was 71 %.

The protein elu-

ted in skewed fashion towards the lower molecular weight range and the
purification of the major activity peak was estimated to be 2.4-fold.
Gel filtration was normally performed with a column buffer containing
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0.1 % NP-40 detergent.

In the absence of detergent, the 5'-deiodinase

eluted from the Sepharose 6B-CL column in the void volume.
Fractionation of the NP-40 membrane extract with ammonium sulfate
and polyethylene glycol resulted in yields of activity in the range of 30
to 50 %.

The losses of enzymatic activity appeared to be due to the in-

complete resolubilization of the precipitated protein.
pr~cipitated

Ammonium sulfate

80 %of the 5'-deiodinase activity at 45 % saturation (4 •c)

with a resulting 1.8-fold purification.

Fractionation with polyethylene

glycol at concentrations of from 10-12 % precipitated 80 % of the activity, however, due to the loss in recoverable activity and a near complete
precipitation of protein, a decrease rather than an increase in specific
activity was observed.
Desalting of 5 1 -deiodinase solutions was performed either by dialys~s

or by Sephadex G-25 gel filtration.

Dialysis overnight in hydroxyla-

patite column buffer at 4 °C resulted in a 30-50 % loss in activity comr
pared to a 0-10 % loss in activity using the Sephadex G-25 column.

An

additional advantage of using Sephadex G-25 chromatography was that it
took less time.
When the NP-40 solubilized 5 1 -deiodinase was concentrated with an
Amicon concentrator using a PM-30

membran~

(30,000 molecular weight cut-

off) at 4 °C, a 10-fold concentration was accompanied by a 90 % loss of
activity.

When mini-columns of hydroxylapatite were used for concentra-

tion, approximately 5 mg of protein was adsorbed per mL of hydroxylapatite resin and the 5'-deiodinase activity was recovered by eluting the
columns with small volumes of 350 mmol/L phosphate elution buffer.
recovery of activity by this method was approximately 100 %.

The
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The Purification Procedure
A multistep purification procedure (Figure 8) was developed based
on detergent solubilization with Nonidet P-40 and the combined use of
three separation techniques that gave promising results in the pilot
studies described above.

Each technique was optimized using the purified

product from the previous step.
carried through the procedure.

Twelve different preparations were
The results described below, for a single

purification attempt, are characteristic of my experience with each step,
and the overall purification scheme.

Preparation of Solubilized Iodothyronine S'-Deiodinase
The crude rat liver homogenate (Fraction A) was prepared for solubilization as described in the Materials and Methods section.

An initial

high speed centrifugation step was used to remove the cell cytosol (Fraction B).

The remaining membrane pellet (Fraction C) retained 92% of the

5'-deiodinase activity and 53 %of the protein from Fraction A.

This

initial purification of the crude homogenate resulted in a 1.7-fold increase in specific activity.

Following the removal of the cell cytosol,

a 2 step selective solubilization of Fraction C was performed with Nonidet P-40.
40.

In the first step, Fraction C was homogenized with 0.05 % NP-

This step solubilized 53 % of the remaining protein and 5 % of the

5'-deiodinase.

The extract (Fraction

c2 )

was discarded.

step, the washed membrane pellet (Fraction
final 0.7 i. NP-40.

c1 )

In the second

was homogenized with a

Approximately 60% of the activity was solubilized

membrane fraction (Fraction E).

The use of 0.7% detergent resulted in a

20% loss in total activity from Fraction

c1 •

The recovery of total
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Figure 8. Flow diagram for the solubilization and purification of
iodothyronine 5'-deiodinase from rat liver homogenate.
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A

37,000 X g
1 hr 4 °CCrude
C Membrane
Preparation
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B Cytosol
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I
~1

Washed
Membrane
Preparation

I 0.05 % NP-40
C2 Extract

Solubilize in
0.7% NP-40
37,000 X g
1 hr 4 °C0.7% NP-40
So 1ub i l ized
D Membrane
Extract
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E Pellet

I DEAE I

Cellulose Chromatography

Fraction I

Hydroxylapatite Chromatography
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Sepharose 6B-CL Chromatography
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protein and total 5'-deiodinase activity from Fraction A is shown in
Table 3.
The solubilized membrane extract (Fraction D) contained 20 % of the
protein and 49 % of the activity of Fraction A, corresponding to a 2.4fold increase in specific activity.

Upon visual inspection, Fraction D

was a slightly viscous, dark brown, turbid solution.

The 5'-deiodinase

activity did not sediment when centrifuged for 60 min at 77,000 x £,
however, the activity was rapidly precipitated when the pH of Fraction D
was adjusted to pH 5.8 or below.

Fraction D could be stored frozen at

-60 °C for up to 6 weeks without a detectable loss 1n 5'-deiodinase
activity.

DEAE Cellulose Chromatography
DEAE cellulose chromatography was used as the first step in the
purification of Fraction D.

The elution profile of protein and 5'-

deiodinase activity from the DEAE cellulose column is shown in Figure 9.
The optimum performance of this step occured at pH 7.6.

The flow rate

was not critical to the performance of the column as long as the sample
front migrated evenly.
factor.

The packing of the column, however, was a major

For optimum performance, the cellulose resin was prepared in

large batches which were equilibrated in column buffer, and the columns
were poured at least 16 h prior to use (See MATERIALS AND METHODS).

A

sample volume of up to 40 % of the bed volume could be applied and as
much as 12 mg protein were adsorbed per milliliter of cellulose.
Approximately 65 % of the protein content of Fraction D and 23 % of
the 5'-deiodinase activity adsorbed to the cellulose resin.

Of the 35 %
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Table 3
Preparation of Nonidet P-40 Solubilized
Iodothyronine 5'-Deiodinase

PROTEIN
(% YIELD)

5 I -DEIODINASE
ACTIVITY
(% YIELD)

100

100

B

47

8

c

53

92

FRACTION*

NONIDET P-40
(g/100 mL)

A**

c1

0.05

25

85

c2

0.05

28

5

D

0.70

20

49

E

0.70

5

19

* See Figure 8 for flow diagram of solubilization.
**Fraction A from 70 g of rat liver tissue contained 7.08 g of protein
and 3,737 units (pmol T3 min-lmg-1) of iodothyronine 5'-deiodinase
activity.
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Figure 9.

DEAE cellulose column chromatography of Fraction D.

120 mL of Fraction D was applied in 30 mL portions to 4 separate
columns containing 2.4 x 16 em beds (68 mL) of DEAE cellulose. Chromatography in each of the 4 columns was performed (4 °C) at a rate of 40
mL/h. Following elution of the bulk of unadsorbed protein (0-100 mL),
Fraction I, as indicated by the bar (~), was collected with an additional 3 bed volumes (205 mL) of column buffer. At the arrow(+), 500
mmol/L NaCl was added to the column buffer to elute the adsorbed protein.
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protein that did not adsorb, 26 % eluted in the first 80 mL of effluent
along with 26 % of the 5'-deiodinase activity and the rema~ning 9 % eluted when an additional 205 mL of column buffer was applied.

This inter-

mediate peak (Fraction I) contained 77 % of the recovered 5'-deiodinase
activity.

The total recovery of protein was approximately 100 % and the

total recovery of enzymatic acti•rity was approximately 127 %.
cellulose step resulted in a 9-fold purification of Fraction D.

The DEAE
In com-

parison to the crude rat liver homogenate (Fraction A), Fraction I contained 1.7 %and 38 %of the original protein and 5'-deiodinase activity
respectively, corresponding to a net 22-fold increase in specific activity.

Hydroxylapatite Chromatography
Due to the large volume of Fraction I (820 mL) and the slow flow
rate (20 mL/h) of the hydroxylapatite column, Fraction I was applied to
the hydroxylapatite gel by batch adsorption.

The quantity of gel added

was ·adjusted so that there would be no more than 4.0 mg protein/mL hydroxylapatite.

The gel slurry was subsequently recovered by low speed cen-

trifugation and packed into a column.

The enzyme was eluted with a step

gradient of increasing phosphate concentration (See Figure 10).
Approximately 16 % of the protein from Fraction I did not adsorb to
the hydroxylapatite gel.
tiv~ty.

There was no detectable unadsorbed enzyme ac-

Elution of the adsorbed protein was carried out 1n 3 steps:

50 mmol/L phosphate buffer eluted 8 % of the protein and 11 % of the
deiodinase.

Fraction II (Figure 10) was recovered with the 130 mmol/L

phosphate elution buffer.

This fraction contained 18 % of the applied

The
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Figure 10.

Hydroxylapatite column chromatography of Fraction I

The combined Fraction I effluent (820 mL) from the DEAE cellulose
chromatography step was applied to 32 mL of hydroxylapatite gel in a 1
liter vessel prior to column chromatography. Details of the procedure
are described in Materials and Methods. The supernatant, containing the
unadsorbed protein was recovered following low speed centrifugation (10
min, 1,000 x ~). The gel, containing the adsorbed protein was packed
into a column, and the resulting· hydroxylapatite bed (2.4 x 9 em) was
washed ~~ith 32 mL of column buffer. Elution of the adsorbed protein was
carried out at a flow rate of 20 mL/h (4 °C) with a step gradient of
increasing phosphate concentration. At the points indicated by the
arrows (+), elution buffers containing: (A) 50 mmol/L, (B) 130 mmol/L
and (C) 400 mmol/L phosphate were added to the column. The 130 mmol/L
phosphate peak (Fraction II), as indicated by the bar (~), was pooled
for gel filtration chromatography.
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protein and 97 % of the applied 5'-deiodinase.

The final 400 mmol/L

phosphate step eluted 57 % of the protein and 5 % of the 5'-deiodinase.
The recovery of protein was nearly complete and the net recovery of 5'deiodinase activity was 113 %.

Fraction II was purified 5.3-fold with

respect to Fraction I and 115-fold relative to the crude rat liver homogenate (Fraction A).

A final 37% yield of 5'-deiodinase activity from

Fraction A was achieved.

Sepharose 6B-CL Chromatography
Sepharose 6B-CL column chromatography of Fraction II was used for
the final step in the purification of the iodothyronine 5'-deiodinase
(~igure

11).

Optimal performance of the gel filtration step was observed.

when the column was run at a flow rate of 20 mL/h and when the column
buffer contained 0.1 % NP-40.

The majority of the 5'-deiodinase activity

eluted from the column in a single sharp peak in the molecular weight
range of 200,000 -350,000.

This peak (Fraction III) contained approxi-

mately 13 % of the protein and 66 % of the 5'-deiodinase activity recovered from Fraction II.

No activity and very little protein was detected

in the void volume, however, an additional 7 % of the deiodinase was recovered in 2 small peaks in the high molecular weight range and in a
trailing of the major activity peak towards the low molecular weight
range.

The total recovery of enzymatic activity from Fraction II was

approximately 73 %.

The gel filtration step increased the specific

activity 5.1-fold.
The final preparation (Fraction III) was purified 580-fold relative
to the crude rat liver homogenate.

The overall recovery of activity was
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Figure 11.

Sepharose 6B-CL column chromatography of Fraction II.

Fraction II from hydroxylapatite chromatography was concentrated to
6 mL and applied to a column of Sepharose 6B-CL (1.5 x 98.5 em). Gel
filtration chromatography was performed at a rate of 20 mL/h (4 °C). The
bar (~) indicates those fractions pooled for Fraction III. a-e indicate the peak volumes for blue dextran and the standard proteins used to
calibrate the column: a, blue dextran; b, thyroglobulin; c, ferritin; d,
catalase; e, aldolase.
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Table 4
Purification of Iodothyronine 5'-Deiodinase
From 70 Grams of Rat Liver

Fraction

Preparation

-----Total___ Enzyme* _ _ _SpeCific*
Volume Protein Concentration
Activity
(mL)
(mg)
(units/mL)
(units/mg)

Total*
Units of
Activity

Recovery Purification
(%)
Factor

A

Crude Rat Liver
Homogenate

250

7082

14.9

0.53

3737

100

1.0

c

Crude Membrane
Preparation

210

3753

16.4

0.92

3451

92

1.7

D

Solubilized
Membrane

120

1416

15.2

1.29

1823

39

2.4

I

DEAE Cellulose

820

123

1.7

11.4

1408

38

21.6

II

Hydroxylapatite

100

22.4

13.7

60.9

1365

37

115

III

Sepharose 6B-CL

15

2.9

59.8

897

24

583

*Units

309

= pmol T3 min-1

00
~
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24% (See Table 4).

The stability of the

pu~ified

enzyme depended on 3

majo~ facto~s:

temperatu~e,

p~esence

of sulfhydryl reducing

equivalents.

pH,

and the

The purified enzyme rapidly precipitated at pH's below 5.8

and the 5'-deiodinase activity was not stable above pH 8.0.
dinase was
pu~ified

insoluble

mo~e

stable at 4 °C than at

The 5'-deio-

~oom temperatu~e, howeve~,

the

5'-deiodinase could not be frozen without the formation of an
p~otein p~ecipitate.

The addition of

dithioth~eitol o~

toethanol had a stabilizing effect on the activity.
(pH 6.5) was

sto~ed

me~captoethanol,

in capped vials at 4 °C in the

When

mercap-

F~action

p~esence

III

of 10 mmol/L

up to 35 % of the 5'-deiodinase activity was lost

ove~

a 2 week period.

Cha~acterization

Unless
were

of Purified

othe~wise

pe~formed

5'-Deiodinase

indicated, the following

on the purified Fraction III

of their purification.

Different enzyme

450- to 600-fold

~elative

Determination of

Molecula~

When the

Iodothy~onine

molecula~

cha~acterization

p~epa~ations

studies

within 2 weeks

p~eparations we~e pu~ified

from

to the crude rat liver homogenate.

Weight

weight of the

iodothy~onine

5'-deiodinase was

approximated by analytical gel filtration chromatography using a Sephacryl S-300 superfine column, a single sharp peak of activity eluted from
the column between the elution volumes of catalase (232,000 daltons) and
ferritin (440,000 daltons), and a molecular weight of 250,000 was estimated for the detergent solubilized deiodinase complex on the basis of
its elution volume relative the protein standards (Figure 12).

The
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Figure 12. Estimation of apparent molecular weight for iodothyronine
5'-deiodinase by gel filtration chromatography on Sephacryl S-300 sf in
the presence of 0.1 % Nonidet P-40.
Details of the experimental procedure are described in Materials
and Methods. The marker proteins used were: ribonuclease A (13,700),
chymotrypsinogen A (25,000), ovalbumin (43,000), bovine serum albumin
(67~000), aldolase (158,000), caialase (232,000), ferritin (440,000) and
thyroglobulin (669,000). The apparent molecular weight of the NP-40
solubilized iodothyronine 5'-deiodinase complex was estimated to be
approximately 250,000.

87

.7

.6
• Chymotrypsinogen A

.5

Kav

.Aidotase
•catalase

.3
IODOTHYRONINE 5

1
-

DEIODINASE

• Ferritin

.2

.I

10

50

100

LOG MOLECULAR WEIGHT

500
X 10

3

88
Stokes radius of the enzyme was estimated to be 5.8 nm.

The molecular

weight of the enzyme was also estimated to be approximately 250,000 when
chromatography was performed using Sephadex G-200 and approximately
280,000 when chromatography was performed using Sepharose 6B-CL.

Isoelectric Focusing of the Nonidet P-40 Solubilized 5'-Deiodinase
The isoelectric point (pi) of the Fraction III iodothyronine S'deiodinase was determined by column electrofocusing in a sucrose stabilized gradient of pH 3-10.
apparent pi of 7.4.

The major activity peak (Figure 13) had an

Minor peaks of activity were observed in the acidic

and basic ends of the pH gradient, however, these were considered to be
artifactual.

When the column polarity was reversed and the vertical col-

umn was run in a descending rather than an ascending manner, a single
major activity peak with a pi of 7.4 was observed and the activity in the
acidic range completely disappeared.

As a result of denaturation during

electrofocusing, recoveries of the Fraction III deiodinase were from 3 to
10 %.

Effect of pH and Temperature
The conversion of T4 to T3 by the detergent solubilized
deiodinase was dependent on pH and temperature.

5'-

The optimal pH was found

to pH 6.5 (Figure 14,A) and the optimal temperature was determined to be
37 °C (Figure 14,B).

There was a sharp drop in activity below pH 5.8,

and the enzyme demonstrated decreased stability above 37 °C.

At 56

the enzyme lost 50% of its activity within 3 minutes (Figure 15).

oc,
A 30

minute preincubation at 56 °C completely inactivated the 5'-deiodinase.
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Figure 13. Isoelectric focusing of iodothyronine 5'-deiodinase in the
presence of 0.1 % Nonidet P-40.
Isoelectric focusing of a 3.0 mg pool of Fraction III protein on a
sucrose gradient was performed in a 1KB 8100 electrofocusing column. The
light gradient solution contained the sample protein, 1.25 m1 of ampholytes (pH 3.5-10), 0.1 % NP-40, and 5 mmol/1 dithiothreitol in a total
volume of 60 m1. The heavy gradient solution contained 46.6 % sucrose,
3.75 mL ampholytes (pH 3.5-10), 0.1% NP-40, and 5mmol/1 dithiothreitol
in a final volume of 60 m1. After forming the sucrose gradient, the sample was focused 48 hours (4 °C) at a final 400 volts, keeping power less
than 1.5 watts throughout, and was eluted with the assistance of a peristaltic pump into 1.5 m1 fractions. ~ , 5~deiodinase activity;
•
• , protein concentration (Bradford); •• • • •·•• , pH. The resolved
peak of iodothyronine 5'-deiodinase activity had a pi of 7.4.
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Figure 14.
activity.

Effect of pH and temperature on iodothyronine 5'-deiodinase

Enzyme assays were varied from standard reaction conditions as
indicated. The rate of T3 formation from ~he deiodination of T4 by Fraction III enzyme was plotted as the mean ± standard devi~tion for triplicate determinations. A. Enzyme assays were buffered with 0.15 mol/L citrate phosphate (pH 4.0-6.0), 0.15 mol/L potassium phosphate (pH 6.0-7.5)
or 0.15 mol/L Tris-HCL (pH 7.5-9.0). In separate experiments, the
citrate and potassium phosphate buffers gave similar results at pH 6.0,
and the phosphate and Tris buffers gave similar results at pH 7.5. B.
Enzyme assays were carried out in water baths thermostated to: 25, 37,
41, 45, 51, and 56 °C.
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Figure 15.

Thermal inactivation of iodothyronine 5'-deiodinase at 56 °C.

Preincubation of Fraction III at 56 °C was carried out for time
intervals of 0 to 40 min. Following preincubation, aliquots of the
.enzyme mixture were assayed at 37 °C for 30 min to determine the
amount of T4 to T3 converting acttvtty rematntng. Data are plotted as
the mean ± standard deviation of triplicate "determinations.
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Linearity With Time and Protein Concentration
A progressive increase of T3 formation with time (Figure 16, A) and
with protein concentration (Figure 16, B) was demonstrated for the detergent solubilized 5'-deiodinase.

The increase with time appeared linear

for the first 60 minutes and gradually fell off thereafter.

Linearity of

activity with protein concentration was observed when velocity determinations were corrected for detergent inhibition.

In contrast, activity

of the crude rat liver homogenate Fractions A and D was not linear with
protein concentration.

Dilution of these fractions resulted in a 3- to

5-fold increase in specific activity.

.

Effect of Substrate and Detergent Concentraeion
Figure 17 shows the interrelationship of thyroxine concentration
and NP-40 concentration on the conversion of T4 to T3 by the partially
purified iodothyronine 5'-deiodinase (Fraction II).

In the absence of

detergent, increasing the substrate concentration from 1
~ol/L

T3.
tion.

~mol/L

T4 to 12

T4 resulted in the formation of progressively larger amounts of

Further increases above 12

~ol/L

T4 resulted in substrate inhibi-

The inhibitory effect of high concentrations of T4 was decreased

when detergent was present in the assay mixture although increasing the
concentration of detergent also had an inhibitory effect on 5'-deiodinase
activity.

The effect of Nonidet P-40 concentration on enzyme activity at

a constant concentration of T4 is shown in Figure 18.

Nonidet P-40 at a

concentration of 0.32 % decreased the activity by 50 %.
In order to compare the inhibitory effect of Nonidet P-40 to that
of deoxycholate (DOC), the activity of Fraction II in the presence of DOC
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Figure 16. Linearity of iodothyronine 5'-deiodinase activity with time
and protein concentration.
The rate of T3 formation·from the deiodination of T4 by Fraction
III was plotted as the mean ± standard deviation for triplicate determinations. A. Enzyme assays were incubated at 37 °C for various periods
of time from 0 to 4 hours. B. Increase in volumes of Fraction III containing from 2 to 25 ~g of protein were added to the enzyme assay mixture
----- , actual 5 '-deiodinase activity observed;
, activity
corrected for Nonidet P-40 inhibition.
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Figure 17. Substrate saturation of iodothyronine 5'-deiodinase activity
in the presence and absence of Nonidet P-40.
100 ~L a1iquots of Fraction II preparations containing: o---o , 0.0
% Nonidet P-40; e---e, 0.1 % Nonidet P-40; ~ , 0.2 % Nonidet P-40;
and .___., 0.5 % Nonidet P-40 were added to enzyme assay mixtures of 1.0
mL final volume. The T4 and T3 converting activity, as a function of T4
concentration for each detergent level was plotted as the mean ± standard
deviation for triplicate determinations.
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Figure 18. Effect of Nonidet P-40 and deoxycholate on iodothyronine
5'-deiodinase activity.
100

aliquots of Fraction II containing increasing concentrations
of~onidet P-40 from 0.025 to 1.0% (w/v) or of deoxycholate from 0.05 to
0.4 % (w/v) were incubated under standard enzyme assay conditions (1.0 mL
final volume). Iodothyronine 5'-deiodinase activity was plotted as the
mean ± standard deviation for triplicate determinations. e
• , %
activity in the presence of Nonidet P-40; o----o , % activity in the
presence of deoxycholate.
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was also studied.
of:

When DOC was added to Fraction II at concentrations

0.05, 0.1, 0.2, 0.4, and 0.8 %, the 5'-deiodinase activity was de-

creased by 64, 83, 92, and 100 %, respectively (See Figure 18).

Activators and Inhibitors
Several thiol group-containing compounds were found to activate the
5'-deiodinase in a concentration dependent manner and to be essential for
activity (Figure 19).

Dithiothreitol had the greatest stimulatory ef-

feet, which plateaued at a concentration of around 20 mmol/L.

Beta-

mercaptoethanol, reduced glutathione, cysteine, and lipoamide also had a
stimulatory effect on the T4 to T3 converting activity.
A number of different agents were tested for possible effects on
the 5'-deiodinase activity of Fraction III (Table 5).

The deiodinase

ha~

no apparent requirement for the presence of metal cofactors or the presence of other cations or anions. EDTA at a 1.0 mmol/L concentration did
not significantly effect deiodinase activity.

Several salts including:

potassium chloride, lithium chloride, sodium iodide, magnesium sulfate,
zinc acetate, mercury chloride and lead nitrate had an inhibitory effect
on deiodinase activity.
potent inhibitor.

Of these compounds, z1nc acetate was the most

Mercury chloride and lead nitrate were not potent in-

hibitors of the 5'-deiodinase in this study due to the presence of 20
mmol/L dithiothreitol, however, when crude rat liver homogenates were
assayed in the absence of dithiothreitol, the addition of 0.2 mmol/L lead
nitrate to the enzyme assay mixture completely inhibited the deiodinase
activity.

This inhibition could be overcome

the addition of dithiothreitol.

~n

a competitive manner with

The conversion of T4 to T3 was also
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Figure 19. Effect of various sulfhydryl reagents on iodonthronine
5'-deiodinase activity.
Fraction III was used as the source of the 5'-deiodinase act1v1ty.
Assays were done under standard conditions (19.3 ~mol/L T4) except for
the variation in cofactor and cofactor concentration. o----o, dithiothreitol (DTT); •
• , Lipcamide; !::r--6., beta mercaptoethanol (BME);
~
~. reduced glutathione (GSH);
o---o, cysteine (Cys).
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Table 5
Effect of Various Agents on Fraction III
5'-Deiodinase Activity
TEST
AGENT

% OF CONTROL*

CONCENTRATION

ACfiVITY

EDTA

1. 0 mmol/L

96 ±

8

NaCL

100.0 mmol/L

104 ±

9

KCL

10.0 mmol/L
20.0 mmol/L

96 ±
82 ±

5

1. 0 mmo1/L
5.0 mmol/L

92 ±
78 ±

6
5

5.0 mmo1/L

106 ±

9

1. 0 mmo1/L

102 ± 10

LiCL

7

MnCL 2

1.0 mmo1/L

96 ±

9

Zn(C 2H302)2

0.1 mmo1/L
1. 0 mmo1/L

21 ±
4 ±

4
2

0.1 mmo1/L

96 ±

9

0.1 mmo1/L

85 ±

7

0.8 mmo1/L

98

±

9

5.0 mmo1/L
10.0 mmo1/L

94 ±

8

82

±

7

5.0 mmol/L

88 ±
48 ±

7
8

5.0 mmol/L

99 ± 10

Nal

1. 0 mmol/L

human serum

15 mg protein/ml

8 ±

2

bovine serum albumin

15 mg protein/ml

38 ±

4

*

mean ± standard deviation for 5 determinations; standard assay
conditions
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inhibited by charcoal stripped serum and to a lesser extent, by bovine
serum albumin.

The activity of the 5'-qeiodinase was not significantly

activated by any of the compounds tested.

It was noted, however, that

ferric chloride enhanced the nonenzymatic, spontaneous deiodination of T4
to T3.

Sodium azide was found to have no effect on T3 formation.
The T4 to T3 converting activity of Fraction III iodothyronine 5'-

deiodinase was unaffected by large doses of dexamethasone and methimazole, however, reverse T3 (rT3), propylthiouracil, propranolol, sodium
salicylate, iodipamide (Cholografin), and to a lesser extent, sodium diatrizoate (Hypaque) inhibited 5'-deiodinase activity in a dose-dependent
manner (Figure 20).

The most potent of these inhibitors was rT3.

tic studies indicated that rT3 was an apparent
of the 5'-deiodinase with respeot to
dithiothreitol (DTT) (K 1
21).

= 0.270

.
both T4

non-competit~ve

inhibitor

and the essential cofactor,
~mol/L,

and 0.099

Kine-

respectively, Figure

Propylthiouracil was an apparent uncompetitive inhibitor with re-

spect to T4 and an apparent competitive inhibitor with respect to DTT (K 1

=

2.62 and 1.16

~mol/L,

respectively, Figure 22).

Sodium salicylate,

Cholografin, and propranolol were apparent competitive inhibitors of the
5'-deiodinase with respect to both T4 (K 1
0.98 mmol/1, respectively) and DTT (K 1

= 75

= 143

~mol/1,

~mol/L,

19.2

10.4

~mol/1

~mol/1,

and
and

2.20 mmol/1, respectively, Figures 23-25).

Determination of Kinetic Parameters and Possible Mechanism of Action
Double reciprocal plots of the Lineweaver-Burke type derived from
kinetic data for the Fraction III 5'-deiodinase generated parallel lines
when velocity versus T4 substrate concentration was plotted for 4
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Figure 20. Comparison of the effect of various inhibitors and related
compounds on iodothyronine 5'-deiodinase activity.
Fraction III was incubated under standard enzyme assay conditions
with the test agents as indicated. •
•, reve~se T3; o----o ,
propylthioutacil (PTU); •
• , iodipamide (cholografin); o----a,
sodium salicyt'ate; ~, propranolol; ...
A, sodium diatrizoate
(hypaque); --------- , dexamethasone; -------------------- , methimazole (Tapazole). An
arbitrary value of 100 was assigned to the amount of T3 produced in the
control tubes containing no inhibitor, and that produced in the presence
of test agent was expressed as a percentage of control values. Each
point is an average of duplicate determinations.
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Figure 21. Apparent non-competitive inhibition by rT3 with respect to T4
and apparent non-competitive inhibition by rT3 with respect to dithiothreitol of T4 to T3 conversion by the Fraction III 5'-deiodinase.
Varying quantities of T4 at a constant 20 mmo1/L dithiothreitol
(A), or varying quantities of dithiothreitol at a constant 19.3 ~mol/L T4
(B) were incubated with 100 ~L Fraction III (0.01 mg protein) in 0.15 mol
phosphate buffer (pH 6.5) for 30 minutes at 37 °C in the absence or
presence of rT3. The amount of T3 generated was quantitated by radioimmunoassay of an ethanol extract of the incubation .mixture. The T4 to
T3 converting activity data was plotted in the form of a Lineweaver-Burke
plot: •
•, 0.0 rT3; •
•, 0.077 ~mol/L rT3; - - - - , 0.154 \lmol/L
rT3; X
>c, 0.230 ~mol/L rT3; o---o , 0.307 lJmol/L rT3. Each point
represents the average of duplicate determinations. The Ki for rT3 was
calculated to be 0.270 ~mol/L with respect to T4 and 0.099 11M with
respect to dithiothreitol.
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Figure 22. Apparent uncompetitive inhibition by propylthiouracil with
respect to T4 and apparent competitive inhibition by propylthiouracil
with respect to dithiothreitol of T4 to T3 conversion by the Fraction III
5'-deiodinase.
The experimental detail as well as the manner o~ plotting the data
are described in Figure 21 for: •
•, 0.0 propylthiouracil (PTU);
e---e , 1. 2 J.lmol/1 PTU; - - - - , 2.4 lJmol/1 PTU; X
x , 3. 5 lJmol/1 PTU;
o---o , 4.7 lJmol/1 PTU. The Ki for PTU was calculated to be 2.62 lJmol/1
with respect to T4 and 1.16 J.lmol/1 with respect to dithiothreitol.

112

-

A

lo

Y.v

E
"'ic

·e
f'()

1-

0
E

Q.

-2

-I

I

2.

3

4

5 _,
( T4. 10 M )

B

Y.v

.08

.06

-

los

•

E

•c:

.04

f'()

1-

0

E

.02

-

c.

-I

113

Figure 23. Apparent competitive inhibition by iodipamide (Cholografin)
with respect to both T4 and dithiothreitol of T4 to T3 conversion by the
Fraction III 5'-deiodinase.
The experimental detail as well as the manner of plotting are described in Figure 21 for:
•
•, 0.0 iodipamide; e---e, 4.5 Umol/L
iodipamide; - - - - , 9.0 Umol/L iodipamide; X
><, 13.6 Umol/L iodipamide; o----o, 18.1 Umol/L iodipamide. The Ki for iodipamide was calculated to be 19.2 umol/L with respect to T4, and 10.4 Umol/L with respect
to dithiothreitol.
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Figure 24. Apparent competitive inhibition by sodium salicylate with
respect to both T4 and dithiothreitol of T4 to T3 conversion by the
Fraction III 5'-deiodinase.
The experimental detail as well as the manner of plotting are described in Figure 21 for:
•
•, 0.0 sodium salicylate; •
•, 125
j..tillol/L sodium salicylate; - - - - , 250 llmol/L sodium salicylate; X
X ,
375 llmol/L sodium salicylate; o
o, 500 llmol/L sodium salicylate. The
Ki for sodium salicylate was calculated to be 75 llmol/L with respect to
T4, and 143 llmol/L with respect to dithiothreitol.
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Figure 25. Apparent competitive inhibition by pro~ranolol with respect
to both T4 and dithiothreitol of T4 to T3 conversion by the Fraction III
5'-deiodinase.
The experimental detail as well as the manner of plotting are described in Figure 21 for:
•
• , 0 propranolol; •
•, .0.42 mmol/1
propranolol;----~, 0.84 mmol/1 propranolol; X
)(, 1.27 mmol/1 propranolol; 0---0 , 1.69 mmol/1 propranolol. The Ki for propranolol was
calculated to be 0.98 mmol/1 with respect to T4, and 2.20 mmol/1 with
respect to dithiothreitol.
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different concentrations of dithiothreitol (Figure 26).
for T4 varied from 1.03
threitol (DTT) to 2.46
The

appa~ent

~mol/L

~mol/1

The apparent Km

T4 at a concentration of 3 mmol/L dithioT4 at a concentration of 12 mmol/L DTT.

maximum velocity (Vmax) was also dependent on DTT concen-

tration and varied from 65.8 pmol T3 min-lmg-1 at a concentration of 3
mmol/L DTT to 162 pmol T3 min-lmg-1 at a concentration ·of 12 mmol/L
DTT.
To determine the true Km for the Fraction III 5'-deiodinase at substrate saturation for T4 and DTT, a double reciprocal plot of apparent Km
T4 values versus DTT concentration was plotted (Figure 27, A).

A line

drawn through the apparent Km T4 values gave a y-intercept of (1/true Km
T4) and ax-intercept of (-1/true Km DTT) (Dixon and Webb, 1979a).
true Km of T4 was calculated to be 5.0

~mol/L

The

T4 and the true Km of DTT

was calculated to be 11.6 mmol/L DTT by this procedure.

The true Vmax at

substrate saturation for T4 and DTT was determined in a similar manner by
a double reciprocal plot of apparent Vmax versus DTT concentration
(Figure 27, B) (Dixon and Webb, 1979a).

They-intercept of this plot

~n

dicated that the true Vmax for iodothyronine 5'-deiodinase was 320 pmol
T3 min-1 mg-1.
In a comparative study, the kinetic parameters of Fraction A (crude
homogenate), Fraction D (solubilized 5'-deiodinase), and Fraction III
(purified 5'-deiodinase) were determined for a constant 20 mmol/L concentration of DTT with varying concentrations of T4.

The velocity versus T4

concentration data were plotted in the form of a double reciprocal plot.
The apparent Km values for Fractions A, D, and III were determined from
the x-intercept of the primary plot to be:

4.25, 4.05, and 4.35

~mol/L

120

Figure 26. Lineweaver-Burk plot of data for the production of T3 from
T4 by the Fraction III 5'-deiodinase at different concentrations of
dithiothreitol (DTT).
Varying quantities of T4 were incubated with: o----c , 3 mmol/L
DTT ; e
e , 6 mmo 1 /L DTT ; D---o , 9 mmo 1 /L DTT ; and •
• , 12 mmo 1 /L
DTT, and 100 ~L of Fraction III (0.01 mg protein) in 0.15 M phosphate
buffer (pH 6.5) for 30 minutes at 37 °C. The amount of T3-generated from
the deiodination of T4 was quantitated by radioimmunoassay of an ethanol
extract of the incubation mixture •. For: 3, 6, 9, and 12 mmol/L DTT, the
apparent Kro values were: 1.03, 1.70, 2.15, and 2.46 ~mol/L T4, respectively and the apparent maximum velocities were: 73, 119, 152, and 182
pmol T3 min-1 mg-1, respectively. The average slope (Kro/Vmax) of the 4
parallel lines was 0.0142.
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Figure 27.
data.

Determination of Km and Vmax values from replots of kinetic

A. A double reciprical plot of the apparent ~ values for T4 from
Figure 26 was plotted with respect to dithiothreitol concentration. A
line drawn through the 4 points had a slope (~ DTT/~ T4) of 2.297. The
y-intercept (1/Km T4) had a value of 2.0 x lOS M-1, and the x-intercept
(1/~ DTT) had a value of -0.871.
a. A double reciprical plot of the apparent VMax values for the conversion of T4 to T3 from Figure 26 was
plotted with respect to dithiothreitol concentration. A line drawn
through the 4 points had a slope (~ DTT/VMax) of 0.0356. The yintercept (1/VMax) had a value of 0.00298, and the x-intercept (1/Km DTT)
had a value of -0.877. From the replots of kinetic data, the true ~ for
T4, the true Km for DTT, and the true VMax for Fraction III were determin~d to be: 5.0 ~mol/L T4, 11.4 mmol/L DTT, and 336 pmol T3 min-lmg-1
respectively.
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T4, respectively and the apparent Vmax values for Fractions A, D, and III
were determined from the y-axis of the primary plot to be:
and 285 pmo1 T3 min-1mg-1, respectively.

0.61, 1.42,

These values represented co~

parative data for conditions approaching substrate saturation.
The fact that the Lineweaver-Burke plot gave parallel lines suggested that the reaction mechanism of the enzyme was that of a two-step
transfer or ping-pong type reaction.

Two additional studies were done to

further investigate the possibility of a two-step transfer mechanism.

In

the first study (Figure 28), enzyme kinetics were performed in the presence of the competitive inhibitor, sodium salicylate.

A double recipro-

cal plot of velocity versus T4 concentration was repeated.

As observed

in the absence of an inhibitor, parallel lines were obtained in the plots
for DTT concentrations of 3, 6, and 12 mmol/L.

In the second study (Fig-

ure 29), T4 and DTT concentrations were increased while a constant ratio
of 2.6

~mol/L

T4 :

1 mmol/L DTT was maintained.

locity of Fraction III deiodinase increased

~n

At this ratio, the ve-

a linear manner over a

range of from 1.3 to 32.2 umol/L T4.

Isotopic Studies of The Deiodination of 125I-T4 and 125I-rT3
The effect of time and pH on the deiodination of 125I-rT3 by Fraction D was studied as shown in Figure 30.

Reverse T3 was rapidly metabo-

lized by the crude enzyme preparation to a 125I-labeled metabolite and
free iodide (125r) (Figure 30, A).

Deiodination of rT3 was nearly co~

plete after 30 minutes, however, the rT3 metabolite was further deiodinated with a corresponding increase in free iodide.

The deiodination of

rT3 by Fraction D occured more rapidly at pH 7.5 than at pH 7.0 or 6.5

125

Figure 28. Demonstration of parallel lines for the Lineweaver-Burk plot
when kinetic data for the conversion of T4 to T3 was generated in the
presence of a competitive inhibitor of T4.
Experimental detial was as described in Figure 26 with the exception that sodium salicylate (75 ~mol/L) was added to the incubation mixture. o
o , 3 mmol/L DTT; o
o , 6 mmol/L DTT; •
• , 12 mmol/L
DTT. The average slope of the 3 parallel lines was 0.0351.
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Figure 29. Linearity of iodothyronine 5'-deiodinase activity with increasing T4 concentrations at a constant molar ratio of T4 to dithiothreitol.
Standard enzyme assay conditions for the incubation of Fraction III
with T4 were altered by varying the concentration-of both T4 and dithiothreitol. As concentrations of T4 were increased from 1.3 to 32.5
~mol/L, the concentration of dithiothreitol was increased from 0.5 to
12.5 mmol/L at a constant ratio of 2.6 ~mol/L T4 to 1.0 mmol/L DTT. Data
are the mean± standard deviation for quadruplicate determinations.
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Figure 30.

Effect of time and pH on the deiodination of rT3 by Fraction

D.
100 ~L of Fraction D containing 1.2 mg of protein was incubated for
0.60 min at 37 °C with 400 ~L of a solution containing 15 ~mol/L rT3, 9.2
~Ci 125r-rT3, 20 mmol/L dithiothreitol, and 100 mmol/L phosphate buffer,
pH 6.5-7.5. The enzyme assay was terminated by adding 50 ~L of a solution containing 2 mol NaOH and 5 mol NaCl. Chromatography of 0.4 mL of
the alkaline extract on Sephadex G-25 sf (See Materials and Methods) resulted in 3 peaks of radioactivity: free iodide cl25r), fractions 8-11;
125r-rT3 metabolite, fractions 14-20; and rT3 (12Sr-rT3), fractions 2230. The results are expressed in terms of percent of total counts (l25r)
for each peak. A. Fraction D was incubated for: 0, 15, 30, or 60 m1nutes in phosphate buffer, pH 7.5. B. Fraction D was incubated for 30
minutes in phosphate buffer, pH 6.5, 7.0, or 7.5.
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(Figure 30, B).
The rate of deiodination of 125I-rT3 with time (Figure 31) and of
125I-T4 with time (Figure 32) was determined for Fraction D, Fraction III
and for a mixture of Fraction D and Fraction III.

The results after 30

minutes and 60 minutes for the deiodination of rT3 and T4, respectively
are presented in Table 6.
During a 30 minute incubation at pH 7.5, Fraction III deiodinated
approximately 4 %of the rT3 substrate (Figure 31, A).

Fraction D deio-

dinated approximately 72 % of the rT3 substrate in the same time period
(Figure 31, B).

During a 60 minute incubation at pH 6.5, Fraction III

and Fraction D deiodinated approximately 8% (Figure 32,·A) and 4% (Figure 32, B) of the T4 substrate, respectively.

Therefore, despite the 2-

fold greater activity of Fraction III in the deiodination of T4, Fraction
III was 18-fold less active than Fraction D in the deiodination of rT3.
When the enzyme assay was run with a mixture containing equal portions of Fraction III and Fraction D, the rate of deiodination of rT3 was
equal to approximately one half that of Fraction D alone (Figure 39, C).
When the mixture of Fraction D and Fraction III was assayed for the deiodination of T4, the rate was approximately 1/3 greater than that of
Fraction D alone (Figure 32, C).
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Figure 31. Comparison of iodothyronine 5'-deiodinase act1v1ty in Fraction III, Fraction Di and a mixture of Fraction D plus Fraction III for
the deiodination of 25I-rT3.
Experimental details were as described in Figure 30. A. 100 ~L
Fraction III containing 10 ~g protein was incubated for 0, 15, 30 and 60
minutes in phosphate buffer, pH 7.5. B. 100 ~L Fraction D conta1n1ng 1.2
mg protein was incubated for 0, 15, 30 and 60 minutes in phosphate buffer, pH 7.5. C. A mixture of SO ~L Fraction D and 50 ~L Fraction III was
incubated for 0, 15, 30, and 60 minutes in phosphate buffer, pH 7.5. The
amount of radioactivity in each of 3 peaks following Sephadex G-25 sf
chromatography was expressed as a percentage of total counts: •
• ,
125I-rT3; o
o, free 12SI; o
o, 12SI-labeled rT3 metabolite.
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Figure 32. Comparison of iodothyronine 5'-deiodinase act1v1ty in Fraction III, Fraction D, and a mixture of Fraction D plus Fraction III for
the conversion of T4 to T3.
100 ~L samples containing: A. Fraction III (10 ~g protein) B.
Fraction D (1.2 mg protein) or C. 50:50 mixture of Fraction D plus Fraction III were incubated for: 0, 30 and 60 minute time intervals at 37 °C
with 400 ~L of a solution.contianing 15 ~mol/L T4, 57.2 ~Ci 125I-T4, 20
mmol/L dithiothreitol and 100 mmol/L phosphate buffer, pH 6.5. The enzyme assay was terminated by adding SO ~L of a solution containing 2
mol/L NaOH and 5 mol/L NaCl. Chromatography of 0.4 mL of the alkaline
extract on Sephadex G-25 sf (See Materials and Methods) resulted in 3
peaks of radioactivity: o----a, free iodide (12SI), fractions 8-11;
o
o, l25I-T3, fractions 14-20; and A
:A, 12SI-T4, fractions 22-30.
The amount of radioactiv-ity in each peak was expressed as a percentage
of total count.
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Table 6
Sum1nary of Results (Figures 31 and 32) For the Deiodination of 125I-rT3
and 125I-T4 BY Fraction D and Fraction III.
DEIODINATION OF 125r-T4

DEIODINATION OF 125I-rT3
PERCENT OF TOTAL COUNTS

SAMPLE
LABEL

PERCENT OF TOTAL COUNTS
LABEL

0 min

30 min

~%

0 min

60 min

~%

Fraction 1I I

125r-rT3
l25I-rT3 metabolite
Free l25I

94.0
2. l
3.9

90.0
3.8
6.0

- 4.0
+ 1. 7
+ 2.1

125I-T4
l25r-T3
Free l25r

86.9
6.1
6.9

78.8
9.4
11.6

-8.1
+3.3
+4. 7

Fraction D

125r-rT3
125r-rT3 metabolite
Free l25r

94.2
3.6
2.2

21.8
40.0
38.2

-72.4
·+36.4
+36.2

125r-T4
125r-T3
Free l25I

86.6
6.1
7.2

82.6
6. l
9.8

-4.0
+1.3
+2.6

l25r-rT3
125I-rT3 metabolite
Free l25I

94.0
3.9
2.0

61.5
20.3
18.0

-32.5
+16.4
+16.0

125I-T4
l25I-T3
Free l25I

86.3
6.3
7.2

81.0
8.4
10.4

-5.3
+2.1
+3.2

Fraction III
&

Fraction D

......
w

0\

CHAPTER IV
DISCUSSION
The enzyme catalyzed conversion of T4 to T3 has been demonstrated
in a number of mammalian tissues (Chopra, 1977a; Cheron
Ishii~~'

~~'

1980;

1981), and has been implicated as the major source of serum

T3 in man (Braverman et

~.,

1970; Chopra, 1978).

The conversion of T4

to T3 involves the removal of a single iodine atom from the C5', position
of the outer iodothyronine rLng and, therefore, the converting enzyme
belongs to a class of enzymes called iodothyronine 5'-deiodinases.

Other

deiodinases which remove an iodine from the inner iodothyronine ring
belong to a second, distinct class of enzymes, the iodothyronine 5deiodinases
~·,

1980).

(Cavalieri~~.,

1977; Kaplan and Utiger, 1978; Gavin et

The present study has delt exclusively with the 5'-

deiodinase whose substrates include thyronines iodinated in the

3'-

and/or 5 1 -positions, and more specifically, with the isolation and characterization of the rat liver 5'-deiodinase that converts T4 to T3.
After a conventional subcellular fractionation of rat

liv~r

homo-

genates, the T4 5'-deiodinase was found to be associated with cellular
membranes rather than cytosolic proteins, and Ln line with previous studies using both rat liver and kidney homogenates
Takaishi

~~·,

1979;

Maciel~~·,

(Visser~~··

1976b;

1979), the greatest yield of thy-

roxine 5'-deiodinase activity was obtained in the crude microsomal preparation.

The crude microsomal fraction, however, contained an average of

no more than 50 % of the total activity, and an increase in specific
137

138
activity of no more than 4-fold.

The majority of the remaining activity

was located in the crude nuclear fraction.

Upon further subfractionation

of the crude microsomal and nuclear fractions, it was discovered that in
addition to the microsomes, the plasma membrane was also an important
source of rat liver 5'-deiodinase activity.

Therefore, rather than using

a microsomal preparation as used in previous studies (Takashi

~~.,

1979; Leonard and Rosenberg, 1980a; Tseng and Latham, 1981), or a plasma
membrane preparation, a cellular membrane preparation containing both
microsomal and plasma membranes was chosen as the starting material for
solubilization and purification of the 5'-deiodinase.

This decision was

made due to the fact that a substantial purification of the enzyme was
not achieved by subcellular fractionation.
The solubilization procedure used in this study was effective in
selectively extracting thyroxine 5'-deiodinase activity from the crude
rat liver membrane preparation.

The yield of solubilized 5'-deiodinase

activity (-60 %) following extraction with Nonidet P-40 was comparable to
that reported previously (60-70 %) for extraction with deoxycholate (Leonard and Rosenberg, 1980a), and the 0.05 -0.7% Nonidet P-40 extract provided a 1.4-fold purification of the crude membrane preparation.

Nonidet
~

P-40 rather than deoxycholate, as used in previous studies (Takaishi
~.,

1979; Leonard and Rosenberg, 1980a; 1980b; Tseng and Latham, 1981),

was chosen for solubilization of the rat liver 5'-deiodinase because the
catalytic activity of the enzyme was much less inhibited in the presence
of Nonidet P-40 than in the presence of deoxycholate (See Figure 18).
a result, enzyme assays could be carried out 1n the presence of low
levels of Nonidet P-40 without the necessity of detergent removal.

An

As
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additional advantage of the use of the nonionic detergent was that losses
of enzyme activity during a single pass through a Sepharose 6B gel infiltration column were in the range of 35-45 % when Nonidet P-40 was used as
the dispersing agent compared to losses in activity of greater than 90 %
when deoxycholate was used as the dispersing agent (Leonard and Rosenberg, 1980a).
The extracted rat liver 5'-deiodinase remained in the supernatant
solution after high speed centrifugation (78,000 x £' 60 min) and, therefore, appeared to be soluble.

The enzyme precipitated following acidifi-

cation (pH 5.8 -6.0), however, in a manner characteristic of detergent
"solubilized" lipoprotein complexes (Penefsky and Tzagoloff, 1971).

The

lipoprotein nature of the Nonidet P-40 solubilized 5'-deiodinase was further supported by demonstrating that the enzyme was poorly soluble in
aqueous buffer.

Thus, while Sepharose 6B-CL chromatography in the pre-

sence of 0.1% Nonidet P-40 allowed elution of the 5'-deiodinase after the
void volume, chromatography in the absence of surfactant resulted in the
formation of macromolecular complexes of the enzyme which eluted in the
void volume.

A similar phenomenon was also reported for the thyroxine

5'-deiodinase extracted from rat liver microsomal preparations with deoxycholate (Leonard and Rosenberg, 1980a).

In addition, evidence of the

intrinsic nature of the 5'-deiodinase, as demonstrated by the fact that
extraction required extensive membrane disassembly (Figures 6 and 7), indicated that the enzyme had a strong association with membrane lipids
(Takaishi

~ ~.,

1979).

Therefore, rather than existing in true solu-

tion, the Nonidet P-40 extracted 5'-deiodinase was apparently suspended
in detergent micelles containing the 5'-deiodinase and associated mem-
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brane phospholipids.
Th~

presence of residual amounts of membrane phospholipid has been

reported to be a requirement of enzymatic activity for the rat liver 5'deiodinase (Leonard and Rosenberg, 1980a).

Therefore, delipidation which

is known to occur in the presence of surfactants during membrane solubilization (Tzagoloff and Penefsky, 1971) and gel filtration

chroma-

tography (Fry and Green, 1980; Penefsky and Tzagoloff, 1971) could explain, in part, losses of activity whch occured in the present study.
Accordingly, optimum conditions for solubilization and purification of
the 5'-deiodinase were empirically determined to maximize stability of
the extracted enzyme complex.

In the present study, the use of Nonidet

P-40 allowed for the first time the solubilization of an active form of
the 5'-deiodinase complex from rat liver membranes which was reasonably
stable in low concentrations of the dispersing detergent.
Prelimina~y

attempts to purify the 5'-deiodinase demonstrated the

usefulness of DEAE cellulose, hydroxylapatite, and Sepharose 6B-CL
chroma-tography ateps in the purification of the Nonidet P-40 solubilized
enzyme.

High yields and increases in relative specific activity follow-

ing each step supported the efficacy of the multistep procedure.

The

first step in the purification scheme involved reverse anion exchange
chromatography on DEAE cellulose.

The majority of the 5'-deiodinase did

not adsorb to the column matrix and was, therefore, separated from the
proteins that did adsorb.

In addition, elution of the 5'-deiodinase from

the cellulose column was retarded, allowing separation of the enzyme from
the bulk of the non-adsorbed protein also.

As a result, the bulk of the

cellulose step allowed purification of the 5'-deiodinase through both ion
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exchange interactions and apparent hydrophobic interactions in a single
step.

The second step involved adsorption chromatography on hydroxylapa-

tite.

The third step, gel filtration chromatography on Sepharose 6B-CL,

permitted the removal of high and low molecular weight contaminants.
enzyme was remarkably stable through all stages of purification.

The

Sur-

prisingly, the first two steps in the purification scheme resulted in a
mild activation of the enzyme.

This behavior was very similar to the en-

hancement of activity following solubilization with deoxycholate
(Takaishi

~~.,

1979) and may have been associated with the removal of

tissue factors which mask enzymatic activity in crude homogenate preparations (Leonard and Rosenberg, 1977).
Purification of the rat liver iodothyronine 5'-deiodinase by the
method reported here resulted in a 580-fold enrichment in specific activity and a 24 % recovery.

The final product was purified from 100 to 300

times greater than microsomal preparations previously used for characterization of the 5'-deiodinase, which had increases in specific activity of
from 2- to 6-fold (Visser et.
Brinke et.

~.,

1979).

~.,

1976b; Hoffken et.

~·,

1978; auf dem

An additional advantage of the purification

scheme was that the final product was prepared in a soluble, yet active
form.

Therefore, detergent removal was not required prior to performing

kinetic determinations.

All previous kinetic studies have been performed

on insoluble enzyme preparations of either cellular membranes or DOC-free
extracts.

The purification procedure used in this study has for the

first time allowed kinetic assays to be performed with a soluble enzyme
preparation.
Upon gel filtration chromatography of the purified 5'-deiodinase, a
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single sharp peak of activity was observed with an apparent molecular
weight of approximately 250,000 and an apparent Stokes' radius of approximately 5.8 nm.

There was no detectable activity at the void volume and

there were no other minor peaks of activity.

Based on results with

deoxycholate solubilized enzyme preparations, where two enzyme forms of
molecular weight 85,000-95,000 and 200,000 were observed (Leonard and
Rosenberg, 1980a; Tseng and Latham, 1981), the Nonidet P-40 solubilized
5'-deiodinase complex may have been a dimer.

The presence of a monomeric

subunit of the 5'-deiodinase may, therefore, have been the cause of the
shoulder in the low molecular weight range during chromatography of Fraction II on Sepharose 6B-CL (Figure 11).

The difference in the molecular

weight estimates of 250,000 in the present study and 200,000 in the previous study was expected on the basis that the nonionic detergents,
Triton X-100 and Nonidet P-40 tend to form larger mixed micelles with
membrane proteins than do anionic detergents (Helenius and Simons,
1975).
Column isoelectric focusing of the purified iodothyronine

5'-

deiodinase resulted in the formation of a single major peak of enzyme
activity which had a pi of 7.4.

The presence of a single peak of activ-

ity indicated that the majority of the Nonidet P-40 solubilized, enzyme
complex existed in a single e1ectrophorectic form.

The formation of

minor peaks of activity were not consistent in size or location and,
therefore, were not considered to be evidence of multiple isoenzyme forms
of the 5'-deiodinase.

Approximately 10 % or less of the applied activity

was recovered due to precipitation of the enzyme despite the presence of
0.1 % Nonidet P-40.

Therefore, isoelectric focusing was not included as
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a preparatory step in the purification scheme.

The procedure would be

advantageous, however, in cases where a high degree of purity is of paramount importance.
The catalytic activity of the purified iodothyronine 5'-deiodinase
was studied under a variety of conditions to determine the parameters
that effect the in vitro conversion of T4 to T3.

It was observed that

factors modulating the 5'-deiodination of T4 included the temperature and
pH of incubation, that activity was linear with respect to protein concentration, and that activity was dependent on the concentration of substrate (T4).

These effects demonstrated that the converting activity of

the Fraction III preparation was enzymatic in nature.
Fraction III iodothyronine 5'-deiodinase activity had an absolute
requirement for sulfhydryl group-containing compounds.

Unlike crude ho-

mogenates which were active in the absence of exogenous cofactor (Chopra,
1977b; Balsam and Ingbar, 1979; Harris et.

~.,

1979), the catalytic

activity of the purified enzyme required the presence of a reduced thiol.
The relative potency of several selected sulfhydryl compounds is shown in
Figure 19.

Dithiothreitol had the greatest stimulatory effect, demon-

strating substratre saturation above a 20 mmol/1 concentration.

Beta-

mercaptoethanol, reduced glutathione, cysteine and lipoamide also had
concentration dependent stimulatory effects.
thiol group was an essential
status of

a

cofacto~,

Due to the fact that the

it was considered to have the

second substrate.

The T4 to T3 converting activity of the purified 5'-deiodinase demonstrated no apparent requirement for the presence of metal cofactors or
for the presence of other monovalent or divalent ions.

In line with
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results from previous studies (Visser~~., 1976b; Chopra, 1976; Sorimachi and Robbins, 1979), EDTA had no effect and ca2+, Mg2+, and Mn2+ at
1 mmol/L concentrations had no effect or only slightly increased the rate
of deiodination.

Ferric ion did not stimulate Fraction III activity,

however, ferric ion did accelerate the nonenzymatic deiodination of T4 in
blank tubes containing heat inactivated enzyme.

Therefore, it was con-

eluded that the stimulation of T4 to T3 conversion by ferric ion reported
previously (Chiraseveenuprapund

~~.,

1978) may have been the result

of chemical rather than enzymatic catalysis.

In the present study, 0.1

mmol/L zn2+ inhibited 5'-deiodinase activity, but it is not known whether
this effect was on the enzyme, on the cofactor, or on the solubility of
the substrate.
Mercury and lead had a potent inhibitory effect on the T4 to T3
converting activity which could be reversed with the addition of dithiothreitol to the incubation mixture.

Due to the catalytic requirement of

the 5'-deiodinase for a thiol cofactor, this effect may have been due to
a sulfhydryl-blocking effect on the cofactor (Chopra, 1977a).

On the

other hand, it has also been demonstrated that the enzyme itself has an
essential sulfhydryl group in its active site (Leonard and Rosenberg,
1980b).

Therefore, the inhibition by heavy metals may also have been due

in part to a direct inhibition of the enzyme.

In either case, the inhi-

bition by mercury and lead was competitive in nature and could be overcome with the addition of dithiothreitol.
Inhibition of 5'-deiodinase activity by bovine serum albumin and by
human serum proteins was observed

~n

the present study as well as in a

previous report (Chiraseveenuprapund et.

~·,

1978).

The nature of the
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inhibition was presumed to be due to the thyroxine binding capacity of
albumin and thyroid binding globulin which are reported to have association constants for thyroxine of 1 x 106 mol-l and 3 x 1olO mol-l, respectively (Nicoloff, 1978).

In a likewise manner, rat liver and kidney mem-

brane proteins which have high affinities for T4 (Oppenheimer and Surks,
1975;

Sterling~~.,

1977; Rall, 1978) have the potential for inter-

fering with the kinetics of 5'-deiodinase activity by lowering the effective substrate concentration.

Therefore, extensive purification of

the enzyme activity is highly desirable prior to the determination of
kinetic parameters.
In addition to the

a~ents

mentioned above, the present study in-

eluded an examination of the effects of several compounds

wh~ch

have been

reported to inhibit either the thyroidal or peripheral metabolism of thyroxine.

Of the compounds tested, the most potent inhibitor of Fraction

III activity was reverse T3.

Preliminary kinetic data from two previous

studies utilizing the crude rat liver homogenate preparations as the
source of 5'-deiodinase activity indicated that rT3 inhibited the

5'-

deiodinase in an apparent competitive manner with respect to T4 (Chopra,
1977a; Kaplan and Utiger, 1978) and, therefore, that T4 and rT3 compete
for the same binding site of the 5'-deiodinase.

On the other hand, my

results with the purified Fraction III enzyme suggest non-competitive
inhibition by rT3.

Non-competitive inhibition suggests that rT3 binds to

a site on the enzyme other than that for the binding of T4 and dithiothreitol and, therefore, that the purified thyroxine 5'-deiodinase has a
minimum of two binding sites for iodothyronines.
II

was reached by Hufner et.

~.,

A similar conclusion

(1977) in a report in which kinetic stu-
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dies were performed with rat liver homogenates.
Inhibition of thyroxine 5'-deiodinase activity by propylthiouracil
(PTU) was observed to occur in the present study and in a previous study
(Chopra, 1977a) in an apparent uncompetitive manner.

This type of inhi-

bition is characteristic of an inhibitor that binds reversibly to an
enzyme-substrate complex but not to the free enzyme.

With regard to the

5'-deiodinase, a likely candidate for an enzyme-substrate complex that
would have a high affinity for PTU is the enzyme-sulfenyl iodide intermediate which has been postulated to result from the deiodination of T4
(Visser et.

~·,

1979b; Leonard and Rosenberg, 1980b).

This hypothesis

is supported by the work of Cunningham, who has shown that PTU readily
forms mixed disulfides with protein-sulphenyl iodide groups (Cunningham,
1964).

It has also been shown that uracil without the sulfur component

is devoid of inhibitory activity (Visser et.

~.,

1979b) and, therefore,

that the affinity of PTU for the enzyme was derived solely from the presence of the thiol group.

Additionally, it was observed that PTU inhi-

bited the 5'-deiodinase in a competitive manner with respect to dithiothreitol.

The competitive nature of the inhibition by PTU could be

explained as a competition between dithiothreitol and PTU for the postulated sulphenyl iodide group.

The data obtained in the present study,

therefore, indicate that the 5'-deiodination of T4 was very similar to
the 5'-deiodination of rT3 which also was inhibited by PTU in an uncompetitive manner with respect to rT3 and in a competitive manner with
respect to dithiothreitol (Visser et.

~.,

1979a).

Other compounds were shown to inhibit the Fraction III 5'deiodinase in a competitive manner.

Iodipamide (Cholografin), an iodi-
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enzyme competitively with respect to both T4 and dithiothreitol.

Other

iodinated x-ray contrast agents such as iopidate (Oragrafin), iopanoic
acid (Telepaque) and sodium tyropanoate (Bilopaque) have also been shown
to be potent dose dependent inhibitors of the T4 to T3 converting enzyme
in rat liver (Kaplan and Utiger, 1978;
tary homogenates

(Larsen~~.,

Chopra~~.,

1978) and pitui-

1979), and Oragrafin, like Cholografin,

has been shown to be a competitive inhibitor with respect to T4 (Chopra
et.

~.,

1978).

The x-ray contrast agents were structurally related to

the idothyronines in that they all contained a saturated phenol ring containing iodine substituant.

Sodium diatrizoate (Hypaque), on the other

hand, did not have an inhibitory effect on the purified 5'-deiodinase despite a similarity in structure to the above mentioned x-ray contrast
agents.

This may have been due to charge repulsion or to steric hin-

drance.
Propranolol, a beta-adrenergic blocking agent commonly used 1n the
treatment of hyperthyroid patients, also demonstrated competitive inhibition in a dose dependent manner with respect to both T4 and dithiothreitol.

Binding affinity was poor, however, and a 2 mmol/L concen-

tration of propranolol was required to inhibit activity by 50 %.
vious studies (Lumholtz et.

~·,

1979; van Noordan et.

~.,

Pre-

1979) have

also demonstrated the in vitro inhibition of 5'-deiodinase activity by
propranolol, but failed to demonstrate a concentration dependent inhibitory effect in their crude enzyme preparations.
treat hyperthyroid patients:

Two other drugs used to

dexamethasone, which has been shown to

decrease the in vivo conversion of T4 to T3, (Croxson et.

~·,

1977;

Chopra et. ~., 1975), and methimazole, an antithyroid agent, (Chira-
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seveenuprapund ~~., 1978) were found not to have an inhibitory effect
on the purified 5'-deiodinase.

These results were also observed in some

other recent studies which employed rat liver (Chopra, 1977a) and kidney
homogenates (Chiraseveenprapund

~~.,

1978).

Sodium salicylate and anilino-naphthalenesulfonic acid (ANS) have
been known for some time to displace T4 and T3 from circulating thyroxine
binding proteins.

More recently, it has been shown that salicylate and

ANS also inhibit the T4 to T3 converting activity of the 5'-deiddinase
(Chiraseveenuprapund

~~.,

1978;

Chopra~~.,

1980).

Therefore,

while the possibility exists that salicylate and ANS may compete with T4
for binding sites of the

5'-deiodinas~

as well as for binding sites of

the transport proteins, these observations have also been interpreted to
indicate that a protein-bound form of T4 could be the normal substrate
for the T4 to T3 converting enzyme (Chiraseveenuprapund

~~.,

1978).

The protein bound to T4 in this case would be an intracellular protein,
not thyroid binding globulin (TBG).

In the present study, the fact that

removal of the soluble proteins (Fraction B) from the membrane preparation (Fraction C) did not result in the loss of enzymatic activity and
the fact that the presence of BSA and human serum strongly inhibited the
catalytic rate strongly suggest that the free form of thyroxine was the
normal substrate for the 5'-deiodinase.
Michaelis-Menten kinetics were observed in the present study for
the conversion of T4 to T3 by the Fraction III 5'-deiodinase when enzyme
assays were carried out in the presence of 0.2 % Nonidet P-40.

Thus,

when kinetic data was plotted in a double reciprical manner for velocity
versus substrate concentration, the data was linear for the range of:
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1 to 20
were

~mol/L

obse~ved

•
arat1ons

(

T4 and 1 to 20 mmol/L dithiothreitol.

Similar results

for kinetic assays carried out with crude rat liver prep-

II
Hufner
et.

~.,

1977; Chopra, 1977a; Kaplan and Utiger, 1978;

Visser, 1979) and crude rat kidney preparations (Leonard and Rosenberg,
1978).

~mol/L

The apparent Km (4.35

T4) determined for the purified

Fraction III 5'-deiodinase was in accordance with values previously
reported for crude preparations of the T4 5'-deiodinase (0.8 to 7.7
~mol/L

II

T4) (Hufner

~~·,

1977; Chopra, 1977a; Kaplan and Utiger,

1978; Leonard and Rosenberg, 1978; auf dem Brinke et.
~~·,

~.,

1979; Visser

1979a) and was approximately equal to the apparent Km of the

Fraction A 5'-deiodinase (4.25
Km of the purified enzyme to

.

~mol/L

~hat

T4).

The close relationship of the

of the crude membrane bound preparation

.

demonstrated that the structural integrity of the detergent solubilized
enzyme had not been greatly altered during solubilization and purification.
The magnitude of T3 generation from T4 by the Fraction III iodothyronine 5'-deiodinase observed in the present study was approximately 300
pmol T3 min-1mg-1.

This result reflects the increased purity of the

Fraction III preparation as compared to the rat liver microsomal preparation (Fraction P) and the crude rat liver homogenate (Fraction A) which
had velocities of 1.81 pmol T3 min-lmg-1 and 0.53 pmol T3 min-1mg-l,
respectively.
of:

These results approximated previously reported velocities

0.04 pmol T3 min-lmg-1 (H~fner ~~·· 1977), 0.13 pmol T3 min-

lmg-1 (Kaplan and Utiger, 1978) and 0.07 pmol T3 min-lmg-1 (Chopra~
~·,

1979) for a rat liver microsomal preparation; and of 1.2 pmol T3

min-1 mg-1 (Leonard and Rosenberg, 1980b)

for a rat kidney microsomal
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preparation.

An earlier report of the velocity for a rat liver micro-

somal preparation of approximately 0.02 pmol T3 min-lmg-1 (Hesch!!~··
1975) was low due to absence of added cofactor (thiol compound such as
mercaptoethanol or dithio-threitol during incubation).

Another report of

a maximum velocity of 63 pmol T3 min-1mg-1 (Visser!!~·· 1979a) for a
rat liver microsomal preparation appeared to be extremely high when compared to previously reported values and those observed in the present
study, especially since the reported purification of the microsomal preparation was only 2-

to 3-fold greater than the crude rat liver homo-

genate which had a reported Vmax of 2.9 pmol T3 min-lmg-1 (Visser et
~·' 1976b).

Among other factors, such as differences in pH, ionic strength, and
T4 substrate concentrations, a major factor contributing to differences
in reported Km and Vmax values for the 5'-deiodinase was differences in
cofactor and cofactor concentration.

In the present study, for example,

an increase in dithiothreitol concentration in the incubation buffer from
3 to 20 mmol/L DTT resulted in an increase in Km of from 1.03 to 4.35
umo1/L T4 and an increase in Vmax of from 65.8 to 285 pmol T3 minlmg-1 for the Fraction III 5'-deiodinase.

Though not as apparent in the

crude rat liver homogenate (Chopra, 1977b), this phenomenon has also been
observed for rat liver microsomal preparations (Visser, 1979) and rat
kidney microsomal preparations (Leonard and Rosenberg, 1978).

Despite

this fact, all previous determinations of kinetic constants for the 5'deiodinase have been calculated for less than optimal cofactor concentrations.

In the present study, replots of the kinetic data (Figure 27)

generated from apparent Km and Vmax values obtained at different concen-
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trations of dithiothreitol were utilized to determine the true kinetic
parameters (Dixon and Webb, 1979a).
The parallel increase in Km and Vmax with increasing dithiothreitol
concentration generated a family of parallel lines when double reciprocal
plots of velocity versus T4 concentration for the 5'-deiodinase were
plotted with respect to varying concentrations of dithiothreitol (Figure
26).

This type of kinetic behavior is characteristic of that observed

for two-step transfer reactions (Cleland; 1963), and indicated that the
conversion of T4 to T3 might occur by a ping-pong type mechanism:
T4

T3

2SH

s-s

+ HI

E-SH
According to the ping-pong reaction mechanism, the reductive deiodination
of T4 would occur in 2 consecutive steps.

In the first step, the C5•-

iodine of the outer ring of T4 would be removed generating the first product, T3.

In the second step, the oxidized enzyme intermediate (E-SI),

which was proposed to be a sulphenyl iodide

(Visser~~.,

1979b; Leo-

nard and Rosenberg, 1980b) would be reduced back to its original active
form (E-SH) and HI would be released as the second product as 2 equivalents of the thiol group-containing cofactor were oxidized.

The occur-

ence of parallel lines in the double reciprocal plot of velocity versus
substrate concentration for different concentrations of cofactor has also
been observed for the conversion of T4 to T3 in rat kidney microsomal
preparations (Leonard and Rosenberg, 1978) and for the conversion of rT3
to 3,3-'T2 in rat liver microsomal preparations (Visser, 1979b), however,
the present data provides the first evidence that the conversion of T4 to
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T3 by the rat liver T4 5'-deiodinase occured by the same mechanism.
The fact that the kinetic data resulted in parallel lines in the
double reciprocal plot suggests, but does not prove that the
deiodinase obeyed a true two-step transfer mechanism.

5'-

Compulsory-order

equilibrium systems also generate parallel lines in double reciprocal
plots when the product of the substrate dissociation constant (Kg) for
substrate A (T4) and the Michaelis-Menten constant (Km) for substrate B
(DTT) are very small in comparison to the product of the concentrations
of substrates a and b (KgA•KmB/a•b) (Dixon and Webb, 1979a).

One way to

distinguish between the two systems is to use a competitive inhibitor of
substrate A.

If the lines in the double reciprocal plot appeared paral-

lel because the value of KgA was very low, carrying out the kinetic
determinations in the presence of a fixed amount of competitive inhibitor
can be used to increase the apparent KgA and thereby result in a convergence of the plotted lines for varying concentrations of substrate B
(Dixon and Webb, 1979b).

Figure 28 shows the double reciprocal plot for

the 5'-deiodinase as determined in the presence of 75

~mol/L

sodium

salicylate which was found in the present study to be a competitive
inhibitor of the Fraction III 5'-deiodinase with respect to both thyroxine and dithiothreitol.

The generation of parallel lines in Figure

28, therefore, gave added support to the hypothesis of ping-pong kinetics.
In the present study, substrate inhibition by T4 was observed at
low detergent concentrations when the concentration of T4 was increased
above 20

~mol/L

T4

~n

the presence of 20 mmol/L DTT (Figure 25), and when

DTT concentrations were increased above 20 mmol/L DTT in the presence of
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ferent isoenzymes of the T4 5'-deiodinase were present in the rat liver
microsomal preparation.

In the present study, no evidence was observed

for the presence of multiple isoenzymes of the T4 to T3 converting enzyme
during the determination of molecular weight and isoelectric point, or
during the determination of catalytic parameters for the purified rat
liver 5'-deiodinase.
The fact that crude rat liver and kidney preparations are active in
the 5'-deiodination of both T4 and rT3, and the observation that the conversion of T4 to T3 and the conversion of rT3 to 3,3' T2 are similar in
many respects has led to an ongoing debate over whether or not the same
enzyme is responsible for the reductive deiodination of the 2 idothyronines.

Evidence supportive of a one enzyme hypothesis is based on the

observations that the subcellular distribution of both activities are
similar (Maciel et

~.,

1979; Leonard and Rosenberg, 1980a), that both

activities are affected in a similar manner by

a

variety of inhibitors

including propylthiouracil, iodoacetic acid and ipodate (Oragrafin)
(Chopra, 1978;

Eisenstein~~.,

1980), and that rT3 and T4 inhibit the

deiodination of each other in a dose dependent manner (Kaplan and Utiger,
1978;

Visser~~·,

1979a).

Evidence supportive of the existence of

separate enzymes for the deiodination of T4 and rT3 is based primarily on
temporal differences in the early abrupt rise in serum T3 concentrations
and the delayed decline in serum rT3 concentrations which occur postnatally in the neonate

(Chopra~~.,

1975a).

These differences have been

interpreted to indicate that the conversion of T4 to T3 and the clearance
of rT3 are carried out by different pathways (Chopra, 1978; Maciel et
~.,

1979).

Additionally, differences in optimum pH observed for the
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conversion of T4 to T3 (pH 6.5) and for the conversion of rT3 to 3,3'-T2
(pH 8.0) (Visser~!!·, 1979a) are also suggestive of the existence of
separate enzymes.

In the present study, enzyme assays utilizing 125I-

labeled substrates demonstrated that the crude solubilized 5'-deiodinase
(Fraction D) was active in the deiodination of both T4 and rT3.

There-

fore, both activities were present in the membrane bound fraction of the
rat liver homogenate and both activities solubilized in an active form in
the presence of Nonidet P-40.

The purified 5 1 -deiodinase preparation

(Fraction III), on the other hand, demonstrated a minimal capacity to
deiodinate rT3.

On an equal volume basis, Fraction III was approximately

20 times less active than the crude preparation in the deiodination of
rT3 despite the fact that it was at least twice as active as Fraction D
in the conversion of T4 to T3.

Therefore, the rT3 deiodinase activity of

Fraction D was either removed or inactivated during purification.

The

fact that the addition of Fraction D to Fraction III did not result in
reactivation of the Fraction III rT3 deiodinase activity suggested that a
loss of cofactor during purification was not responsible for the low rT3
deiodinase activity of the Fraction III preparation.

The failure of the

rT3 5'-deiodinase activity to co-purify with the T4 5'-deiodinase plus
the fact that the deiodination of T4 and rT3 occured optimally at pH 6.5
and pH 7.5 or higher, respectively is, therefore, strongly suggestive
that different enzymes might be involved in the deiodination of T4 and
rT3.

SUMMARY
Recent reports of reciprocal changes in serum

3,3,5'-triiodo-

thyronine (T3) and 3,3' ,5 1 -triiodothyronine (rT3) levels during starvation, stress and febrile illness have stimulated interest in what appears
to be a physiologically regulated, control mechanism whereby the body can
fine~

the biological effects of the thyroid hormones.

A previously

unpurified, membrane-bound iodothyronine 5'-deiodinase, which activates
thyroxine (T4) by converting it to the more physiologically active hormone T3, is thought to be primarily responsible for control of this pathway.
The purpose of this study was to solubilize and partially purify
the iodothyronine 5'-deiodinase from rat liver membranes and to characterize the purified enzyme in terms of substrate specificity, catalytic
parameters, molecular weight, and isoelectric point.

The mechanism of

action of the enzyme was also examined.
Results indicated that 0.7% Nonidet P-40 was effective in solubilizing up to 60 % of the 5'-deiodinase activity from rat liver membranes.
After solubilization, the 5'-deiodinase was purified 580-fold.

The puri-

fied enzyme eluted in a single peak during analytical gel filtration, and
a single peak of 5'-deiodinase activity was also observed during isoelectric focusing.

The active complex had an apparent molecular weight of

250,000 and an apparent isoelectric point of 7.4.
Kinetic assays demonstrated that the purified 5'-deiodinase was
optimally active at 37 °C and pH 6.5, and that there was an absolute re156
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quirement for the presence of a thiol group-containing cofactor.

The

most potent cofactor, dithiothreitol (DDT), was used in this work.

The

Km value for T4 was dependent on the concentration of cofactor and parallel lines in the Lineweaver-Burk plot were generated when kinetic data
for the conversion of T4 to T3 were plotted for varying concentrations of
DTT.

This data as well as other observed catalytic properties of the

purified enzyme were consistent with the hypothesis of a ping-pong mechanism of action for the rat liver T4 5'-deoidinase.

At saturating sub-

strate and cofactor conditions, the Km values for T4 and DDT were determined to be 5.0

~mol/L

and 11.4 mmol/L, respectively, and the Vmax for

the purified enzyme was 320 pmol T3 min-lmg protein-1.

Reverse T3 was an

apparent non-competitive inhibitor with respect to both T4 and DTT.
Cholografin, sodium salicylate and propranolol were dose dependent, comr
petitive inhibitors with respect to both T4 and DTT.

Propylthiouracil

inhibited the reaction un-competitively with respect to T4 and competitively with respect to DTT.
Despite a high binding affinity for rT3 (K 1

= 9.9

x lo-8 mol/L),

the purified 5'-deiodinase did not actively deiodinate rT3.
These data suggest the existence of a single specific thryoxine 5'deiodinase in rat liver membranes that catalyzes the conversion of T4 to
T3, and that can be solubilized and purified in the presence of Nonidet
P-40 as a dispersing agent.

The fact that the purified enzyme did not

catalyze the 5'-deiodination of rT3 is interesting because it suggests
the possible existence of a specific reverse T3 5'-deiodinase, and therefore, that the peripheral deiodination scheme for the iodothyronines may
be more complex than orignally anticipated.
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